Set Analyses:
Advanced Search

Advanced Search

 
Search By
Section (entire)
for


 



IDO1 Gene

protein-coding   GIFtS: 65
GCID: GC08P039771

Indoleamine 2,3-Dioxygenase 1

(Previous name: indoleamine-pyrrole 2,3 dioxygenase)
(Previous symbols: IDO, INDO)
  See IDO1-related diseases
at  

(According to 1HGNC, 2Entrez Gene,
3UniProtKB/Swiss-Prot, 4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc, 7Ensembl, 8DME, 9miRBase, 10fRNAdb, 12H-InvDB, 13NCBI, 14NONCODE, and/or 15RNAdb)
About This Section

TryGeneCards Plus

Aliases
Indoleamine 2,3-Dioxygenase 11 2     Indoleamine-Pyrrole 2,3 Dioxygenase1
IDO1 2 3 5     Indolamine 2,3 Dioxygenase2
INDO1 2 3 5     Indole 2,3-Dioxygenase2
Indoleamine-Pyrrole 2,3-Dioxygenase2 3     EC 1.13.11.523
IDO-12 3     

External Ids:    HGNC: 60591   Entrez Gene: 36202   Ensembl: ENSG000001312037   OMIM: 1474355   UniProtKB: P149023   

Export aliases for IDO1 gene to outside databases

Previous GC identifers: GC08P039891 GC08P038304


(According to Entrez Gene, GeneCards, Tocris Bioscience, Wikipedia's Gene Wiki, PharmGKB,
UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL)
About This Section

TryGeneCards Plus

Entrez Gene summary for IDO1 Gene:
This gene encodes indoleamine 2,3-dioxygenase (IDO) - a heme enzyme that catalyzes the first and rate-limiting
step in tryptophan catabolism to N-formyl-kynurenine. This enzyme acts on multiple tryptophan substrates
including D-tryptophan, L-tryptophan, 5-hydroxy-tryptophan, tryptamine, and serotonin. This enzyme is thought to
play a role in a variety of pathophysiological processes such as antimicrobial and antitumor defense,
neuropathology, immunoregulation, and antioxidant activity. Through its expression in dendritic cells, monocytes,
and macrophages this enzyme modulates T-cell behavior by its peri-cellular catabolization of the essential amino
acid tryptophan.(provided by RefSeq, Feb 2011)

GeneCards Summary for IDO1 Gene:
IDO1 (indoleamine 2,3-dioxygenase 1) is a protein-coding gene. Diseases associated with IDO1 include toxic oil syndrome, and listeriosis. GO annotations related to this gene include electron carrier activity and indoleamine 2,3-dioxygenase activity. An important paralog of this gene is IDO2.

UniProtKB/Swiss-Prot: I23O1_HUMAN, P14902
Function: Catalyzes the cleavage of the pyrrol ring of tryptophan and incorporates both atoms of a molecule of
oxygen

Gene Wiki entry for IDO1 (Indoleamine 2,3-dioxygenase) Gene


(According to GeneLoc and/or HGNC, and/or
Entrez Gene (NCBI build 37),
and/or miRBase,
Genomic Views according to UCSC (hg19) and Ensembl (release 75), Regulatory elements and Epigenetics data according to QIAGEN, and/or SwitchGear Genomics)
About This Section

TryGeneCards Plus
RefSeq DNA sequence at NCBI GenBank:
NC_000008.10  NC_018919.2  NT_167187.2  
Regulatory elements:
   Regulatory transcription factor binding sites in the IDO1 gene promoter:
         GR   AML1a   GR-beta   LUN-1   NF-kappaB   HNF-4alpha1   GR-alpha   NF-kappaB1   
         Other transcription factors

SwitchGear Promoter luciferase reporter plasmidIDO1 promoter sequence
   Search Chromatin IP Primers for IDO1

Epigenetics:
DNA Methylation CpG Assay Predesigned for Pyrosequencing in human, mouse, rat IDO1


Genomic Location:
Genomic View: UCSC Golden Path with GeneCards custom track

Entrez Gene cytogenetic band: 8p12-p11   Ensembl cytogenetic band:  8p11.21   HGNC cytogenetic band: 8p12-p11

IDO1 Gene in genomic location: bands according to Ensembl, locations according to (and/or Entrez Gene and/or Ensembl if different)
IDO1 gene location

GeneLoc information about chromosome 8         GeneLoc Exon Structure

GeneLoc location for GC08P039771:  view genomic region     (about GC identifiers)

Start:
39,759,794 bp from pter      End:
39,786,309 bp from pter
Size:
26,516 bases      Orientation:
plus strand

(According to 1UniProtKB, HORDE, 2neXtProt, Ensembl, and/or Reactome, Modification sites according to PhosphoSitePlus, Specific Peptides from DME, RefSeq according to NCBI, PDB rendering according to OCA and/or Proteopedia, Recombinant Proteins from EMD Millipore, R&D Systems, GenScript, Enzo Life Sciences, OriGene, Novus Biologicals, Sino Biological, ProSpec, Cloud-Clone Corp., and/or eBioscience,
Biochemical Assays by EMD Millipore, R&D Systems, OriGene, GenScript, Cell Signaling Technology, Enzo Life Sciences, Cloud-Clone Corp., and/or eBioscience, Antibodies by EMD Millipore, R&D Systems, Cell Signaling Technology, OriGene, Novus Biologicals, Thermo Fisher Scientific, LSBio, Abcam, Cloud-Clone Corp, and/or others.)
About This Section

TryGeneCards Plus

UniProtKB/Swiss-Prot: I23O1_HUMAN, P14902 (See protein sequence)
Recommended Name: Indoleamine 2,3-dioxygenase 1  
Size: 403 amino acids; 45326 Da
Cofactor: Binds 1 heme group per subunit
2 PDB 3D structures from and Proteopedia for IDO1:
2D0T (3D)        2D0U (3D)    
Secondary accessions: Q540B4

Explore the universe of human proteins at neXtProt for IDO1: NX_P14902

Explore proteomics data for IDO1 at MOPED

Post-translational modifications: 

  • Modification sites at neXtProt
  • Modification sites at PhosphoSitePlus

  • See IDO1 Protein Expression from SPIRE MOPED, PaxDB, and MaxQB

    REFSEQ proteins: NP_002155.1  
    ENSEMBL proteins: 
     ENSP00000429297   ENSP00000428716   ENSP00000430505   ENSP00000429933   ENSP00000430950  
     ENSP00000253513  
    Reactome Protein details: P14902

    IDO1 Human Recombinant Protein Products:

    Browse Purified and Recombinant Proteins at EMD Millipore
    R&D Systems Recombinant & Natural Proteins for IDO1 (Indoleamine 2,3-dioxygenase/IDO)
    Enzo Life Sciences proteins for IDO1
    OriGene Purified Protein for IDO1
    OriGene Protein Over-expression Lysate for IDO1
    OriGene MassSpec for IDO1
    OriGene Custom Protein Services for IDO1
    GenScript Custom Purified and Recombinant Proteins Services for IDO1
    Novus Biologicals IDO1 Protein
    Novus Biologicals IDO1 Lysates
    Sino Biological Recombinant Protein for IDO1
    Browse Sino Biological Cell Lysates
    Browse ProSpec Recombinant Proteins
    Browse Proteins at Cloud-Clone Corp.

     
    Search eBioscience for Proteins for IDO1 

    IDO1 Antibody Products:

    EMD Millipore Mono- and Polyclonal Antibodies for the study of IDO1
    R&D Systems Antibodies for IDO1 (Indoleamine 2,3-dioxygenase/IDO)
    Cell Signaling Technology (CST) Antibodies for IDO1  (INDO)
    OriGene Antibodies for IDO1
    OriGene Custom Antibody Services for IDO1
    Novus Biologicals IDO1 Antibodies
    Abcam antibodies for IDO1
    Browse Antibodies at Cloud-Clone Corp.
    ThermoFisher Antibody for IDO1
    LSBio Antibodies in human, mouse, rat for IDO1

    IDO1 Assay Products:

    Browse Kits and Assays available from EMD Millipore
    OriGene Custom Assay Services for IDO1
    R&D Systems Proteome Profiler Antibody Arrays for IDO1 (Indoleamine 2,3-dioxygenase/IDO)
    GenScript Custom Assay Services for IDO1
    Browse Enzo Life Sciences for kits & assays
    Browse ELISAs at Cloud-Clone Corp.
    Browse CLIAs at Cloud-Clone Corp.
    Search eBioscience for ELISAs for IDO1 


    (According to HGNC, IUPHAR, InterPro, ProtoNet, UniProtKB, and/or BLOCKS, Sets of similar genes according to GeneDecks)
    About This Section

    TryGeneCards Plus
    1 InterPro protein domain:
     IPR000898 Indolamine_dOase

    Graphical View of Domain Structure for InterPro Entry P14902

    ProtoNet protein and cluster: P14902

    1 Blocks protein domain: IPB000898 Indoleamine 2,3-dioxygenase

    UniProtKB/Swiss-Prot: I23O1_HUMAN, P14902
    Similarity: Belongs to the indoleamine 2,3-dioxygenase family


    Find genes that share domains with IDO1           About GenesLikeMe


    (According to 1UniProtKB, Genatlas, LifeMap Discovery™, IUBMB, and/or 2DME, Human phenotypes from GenomeRNAi, Animal models from MGI Mar 06 2013, inGenious Targeting Laboratory, genOway,
    transcription factor targeting from QIAGEN and/or HOMER, miRNA Gene Targets from miRTarBase, shRNA from OriGene, siRNAs from OriGene, QIAGEN, microRNA from QIAGEN, SwitchGear Genomics, Gene Editing from DNA2.0, Clones from OriGene, GenScript, Sino Biological, DNA2.0, Vector BioLabs and/or Addgene, Cell Lines from GenScript, ESI BIO, In Situ Hybridization Assays from Advanced Cell Diagnostics, Flow cytometry from eBioscience, Ontologies according to Gene Ontology Consortium 01 Apr 2014 via Entrez Gene.)
    About This Section

    TryGeneCards Plus

    Molecular Function:

         UniProtKB/Swiss-Prot Summary: I23O1_HUMAN, P14902
    Function: Catalyzes the cleavage of the pyrrol ring of tryptophan and incorporates both atoms of a molecule of
    oxygen
    Catalytic activity: D-tryptophan + O(2) = N-formyl-D-kynurenine
    Catalytic activity: L-tryptophan + O(2) = N-formyl-L-kynurenine
    Enzyme regulation: Activity is inhibited by and MTH-trp (methylthiohydantoin-DL-tryptophan), modestly inhibited by
    L-1MT (1-methyl-L-tryptophan) but not D-1MT (1-methyl-D-tryptophan)
    Biophysicochemical properties: Kinetic parameters: KM=21.23 uM for L-tryptophan; KM=4.6 mM for D-tryptophan;
    Note=Catalytic efficiency for L-tryptophan is 150 times higher than for D-tryptophan;
    Induction: By IFNG/IFN-gamma

         Enzyme Number (IUBMB): EC 1.13.11.521

         Gene Ontology (GO): Selected molecular function terms (see all 6):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0004833tryptophan 2,3-dioxygenase activity EXP--
    GO:0005515protein binding ----
    GO:0009055electron carrier activity TAS2109605
    GO:0020037heme binding IEA--
    GO:0033754indoleamine 2,3-dioxygenase activity IEA--
         
    Find genes that share ontologies with IDO1           About GenesLikeMe


    Phenotypes:
         5 MGI mutant phenotypes (inferred from 2 alleles(MGI details for Ido1):
     cellular  hematopoietic system  homeostasis/metabolism  immune system  reproductive system 

    Find genes that share phenotypes with IDO1           About GenesLikeMe

    Animal Models:
         MGI mouse knock-out Ido1tm1Alm for IDO1

       inGenious Targeting Laboratory: Let us create your new Knockout/Knockin mouse model for IDO1
       inGenious Targeting Laboratory: Contact us about creating complex and humanized mouse models for IDO1

       genOway customized KO model: permanent, tissue-specific or time-controlled inactivation for IDO1
       genOway customized Knockin model: humanization, point mutation, expression monitoring, etc. for IDO1

    miRNA
    Products:
        
    Block miRNA regulation of human, mouse, rat IDO1 using miScript Target Protectors
    Search for qRT-PCR Assays for microRNAs that regulate IDO1
    SwitchGear 3'UTR luciferase reporter plasmidIDO1 3' UTR sequence
    Inhib. RNA
    Products:
        
    OriGene RNAi products in human, mouse, rat for IDO1
    Predesigned siRNA for gene silencing in human, mouse, rat IDO1

    Gene Editing
    Products:
    DNA2.0 Custom Protein Engineering Service for IDO1

    Clone
    Products:
         
    OriGene clones in human, mouse for IDO1 (see all 6)
    OriGene ORF clones in mouse, rat for IDO1
    OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
    GenScript: all cDNA clones in your preferred vector: IDO1 (NM_002164)
    Sino Biological Human cDNA Clone for IDO1
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for IDO1
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat IDO1

    Cell Line
    Products:
         
    GenScript Custom overexpressing Cell Line Services for IDO1
    Browse ESI BIO Cell Lines and PureStem Progenitors for IDO1 
    In Situ Assay
    Products:
       

     
    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for IDO1


    (According to UniProtKB, COMPARTMENTS Subcellular localization database, Ontologies according to Gene Ontology Consortium 01 Apr 2014 via Entrez Gene.)
    About This Section

    TryGeneCards Plus

    Subcellular locations from COMPARTMENTS: 

    CompartmentConfidence
    cytosol4
    extracellular2
    nucleus2
    cytoskeleton1
    mitochondrion1
    peroxisome1
    plasma membrane1

    Gene Ontology (GO): 4 cellular component terms:    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0005737cytoplasm ----
    GO:0005829cytosol TAS--
    GO:0030485smooth muscle contractile fiber IEA--
    GO:0032421stereocilium bundle IEA--

    Find genes that share ontologies with IDO1           About GenesLikeMe


    (SuperPaths according to PathCards, Pathways according to R&D Systems, Cell Signaling Technology, KEGG, PharmGKB, BioSystems, Sino Biological, Reactome, Tocris Bioscience, GeneGo (Thomson Reuters), QIAGEN, and/or UniProtKB, Sets of similar genes according to GeneDecks, Interaction Networks according to QIAGEN, and/or STRING, Interactions according to 1UniProtKB, 2MINT, 3I2D, and/or 4STRING, with links to IntAct and Ensembl, Ontologies according to Gene Ontology Consortium 01 Apr 2014 via Entrez Gene).
    About This Section

    TryGeneCards Plus

    SuperPaths for IDO1 About   (see all 6)  
    See pathways by source

    SuperPathContained pathways About
    1Tryptophan metabolism
    Tryptophan metabolism0.46
    Tryptophan catabolism0.00
    Tryptophan metabolism0.46
    2Metabolism
    Metabolism0.38
    Metabolic pathways0.38
    3Metabolism of amino acids and derivatives
    Metabolism of amino acids and derivatives
    tryptophan degradation via kynurenine0.00
    4Nicotinate and nicotinamide metabolism
    NAD metabolism0.43
    5Lymphocyte Signaling
    Lymphocyte Signaling


    Find genes that share SuperPaths with IDO1           About GenesLikeMe

    Pathways by source                                                                                                                                                                 See SuperPaths
    Show all pathways


    1 Cell Signaling Technology (CST) Pathway for IDO1
        Lymphocyte Signaling

    1 GeneGo (Thomson Reuters) Pathway for IDO1
        NAD metabolism

    2 BioSystems Pathways for IDO1
        tryptophan degradation via kynurenine
    Tryptophan metabolism


    1 Reactome Pathway for IDO1
        Tryptophan catabolism


    3 Kegg Pathways  (Kegg details for IDO1):
        Tryptophan metabolism
    Metabolic pathways
    African trypanosomiasis

    UniProtKB/Swiss-Prot: I23O1_HUMAN, P14902
    Pathway: Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan:
    step 1/2

        Pathway & Disease-focused RT2 Profiler PCR Arrays including IDO1: 

              Amino Acid Metabolism I in human mouse rat
              T-Cell Anergy & Immune Tolerance in human mouse rat

    Interactions:

        GeneGlobe Interaction Network for IDO1

    STRING Interaction Network Preview (showing 5 interactants - click image to see 25)

    Selected Interacting proteins for IDO1 (P149022, 3 ENSP000002535134) via UniProtKB, MINT, STRING, and/or I2D (see all 29)
    InteractantInteraction Details
    GeneCardExternal ID(s)
    PPP1R16AQ96I342, 3MINT-65182 I2D: score=6 
    DDX24Q9GZR72, 3, ENSP000003286904MINT-65410 I2D: score=5 STRING: ENSP00000328690
    UBCP0CG483, ENSP000003448184I2D: score=1 STRING: ENSP00000344818
    AANATENSP000002506154STRING: ENSP00000250615
    AFMIDENSP000003289384STRING: ENSP00000328938
    About this table

    Gene Ontology (GO): Selected biological process terms (see all 21):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0002534cytokine production involved in inflammatory response IEA--
    GO:0002666positive regulation of T cell tolerance induction IEA--
    GO:0002678positive regulation of chronic inflammatory response IEA--
    GO:0002830positive regulation of type 2 immune response IEA--
    GO:0006569tryptophan catabolic process TAS--

    Find genes that share ontologies with IDO1           About GenesLikeMe



    (Chemical Compounds according to UniProtKB, Enzo Life Sciences, EMD Millipore, Tocris Bioscience, ApexBio, HMDB, BitterDB, and/or Novoseek, Ligands according to IUPHAR, and Drugs according to DrugBank, Enzo Life Sciences, and/or PharmGKB)
    About This Section

    TryGeneCards Plus
    Browse Small Molecules at EMD Millipore
       Enzo Life Sciences drugs & compounds for IDO1
      Browse compounds at ApexBio 

    Browse Tocris compounds for IDO1 (I23O1)

    9 HMDB Compounds for IDO1    About this table
    CompoundSynonyms CAS #PubMed Ids
    Melatonin5-Methoxy-N-acetyltryptamine (see all 23)73-31-415636586
    5-Hydroxy-L-tryptophan(+-)-5-Hydroxytryptophan (see all 21)4350-09-8--
    5-Hydroxy-N-formylkynurenine ----
    D-Tryptophan(+)-tryptophan (see all 19)153-94-6--
    Formyl-5-hydroxykynurenamine3-(N-Acetylaminoethyl)-6-hydroxy-5-methoxyindole (see all 7)2208-41-5--
    Heme(protoporphyrinato)iron (see all 19)14875-96-8--
    L-Tryptophan(-)-tryptophan (see all 53)73-22-3--
    OxygenOxygen (see all 5)7782-44-7--
    Serotonin3-(2-Aminoethyl)-1H-indol-5-ol (see all 14)50-67-9--

    2 DrugBank Compounds for IDO1    About this table
    CompoundSynonyms CAS #TypeActionsPubMed Ids
    L-Tryptophan(-)-Tryptophan (see all 14)73-22-3enzymesubstrate17417651 16842443 17430109 17015752 11752352 16887964 19290871
    MelatoninMEL (see all 4)73-31-4enzymesubstrate15636586

    Selected Novoseek inferred chemical compound relationships for IDO1 gene (see all 57)    About this table
    Compound   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    indoleamine 99.1 465 18612775 (2), 19519465 (2), 17942160 (2), 15063631 (2) (see all 99)
    kynurenine 97.2 292 10756023 (6), 8293279 (5), 19327051 (5), 10731095 (4) (see all 99)
    1-methyltryptophan 95.2 71 18418598 (5), 16887964 (3), 17605849 (2), 17234791 (2) (see all 29)
    1-methyl-d-tryptophan 90.2 14 15281097 (1), 17114500 (1), 18832696 (1), 17945538 (1) (see all 8)
    n-formylkynurenine 88.7 14 8288893 (1), 1591013 (1), 15206718 (1), 19275153 (1) (see all 14)
    3-hydroxyanthranilic acid 84.4 10 11392499 (2), 10731095 (1), 20484731 (1), 11798468 (1) (see all 8)
    l-tryptophan 83.5 56 18639341 (4), 10731095 (3), 19264674 (2), 7814143 (2) (see all 37)
    quinolinic acid 82.5 24 17457312 (2), 18063923 (2), 19958238 (2), 14592780 (1) (see all 20)
    neopterin 81 19 19765856 (2), 15302611 (1), 17136028 (1), 7790043 (1) (see all 17)
    indolamine 80.4 11 10206145 (2), 15516717 (1), 19079205 (1), 17157205 (1) (see all 10)

    2 PharmGKB related drug/compound annotations for IDO1 gene    About this table
    Drug/compound PharmGKB Annotation
    interferon alfa-2a, recombinantCA  
    peginterferon alfa-2bCA  



    Find genes that share compounds with IDO1           About GenesLikeMe



    (Secondary structures according to fRNAdb,
    GenBank/EMBL/DDBJ Accessions according to
    Unigene (Build 236 Homo sapiens; Apr 25 2013) or GenBank,
    RefSeq according to Entrez Gene,
    DOTS (version 10), and/or AceView, transcript ids from Ensembl with links to UCSC,
    exon structure from GeneLoc, alternative splicing isoforms according to ASD and/or ECgene,
    siRNAs from OriGene, QIAGEN, shRNA from OriGene, microRNA from QIAGEN, SwitchGear Genomics,
    Tagged/untagged cDNA clones from OriGene, GenScript, DNA2.0, Vector BioLabs, and/or Addgene, Primers from OriGene, and/or QIAGEN, Flow cytometry from eBioscience )
    About This Section

    TryGeneCards Plus

    REFSEQ mRNAs for IDO1 gene: 
    NM_002164.5  

    Unigene Cluster for IDO1:

    Indoleamine 2,3-dioxygenase 1
    Hs.840  [show with all ESTs]
    Unigene Representative Sequence: NM_002164
    9 Ensembl transcripts including schematic representations, and UCSC links where relevant:
    ENST00000518804 ENST00000519154 ENST00000522495 ENST00000522840 ENST00000518237(uc003xnm.3)
    ENST00000253513 ENST00000521636 ENST00000521480 ENST00000523779
    miRNA
    Products:
         
    Block miRNA regulation of human, mouse, rat IDO1 using miScript Target Protectors
    Search for qRT-PCR Assays for microRNAs that regulate IDO1
    SwitchGear 3'UTR luciferase reporter plasmidIDO1 3' UTR sequence
    Inhib. RNA
    Products:
         
    OriGene RNAi products in human, mouse, rat for IDO1
    Predesigned siRNA for gene silencing in human, mouse, rat IDO1
    Clone
    Products:
         
    OriGene clones in human, mouse for IDO1 (see all 6)
    OriGene ORF clones in mouse, rat for IDO1
    OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
    GenScript: all cDNA clones in your preferred vector: IDO1 (NM_002164)
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for IDO1
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat IDO1
    Primer
    Products:
        
    OriGene qPCR primer pairs and template standards for IDO1
    OriGene qSTAR qPCR primer pairs in human, mouse for IDO1
    Pre-validated RT2 qPCR Primer Assay in human, mouse, rat IDO1
      QuantiTect SYBR Green Assays in human, mouse, rat IDO1
      QuantiFast Probe-based Assays in human, mouse, rat IDO1

    Additional mRNA sequence: 

    AK313259.1 AY221100.1 BC027882.1 JF772862.1 M34455.1 X17668.1 

    8 DOTS entries:

    DT.408798  DT.100691410  DT.100788833  DT.65287506  DT.95330370  DT.92018039  DT.92451035  DT.95216114 

    Selected AceView cDNA sequences (see all 86):

    X17668 AL549895 CR613807 BE466403 CB118974 CD369108 CR591703 AU137351 
    CA432661 AA478279 BX113985 CB529600 CR621546 CD742761 AL549011 AA478338 
    AY221100 AI308058 BC027882 NM_002164 CB217134 AL545869 CR616634 AL554455 

    GeneLoc Exon Structure


    (RNA expression data according to H-InvDB, NONCODE, miRBase, and RNAdb, Expression images according to data from BioGPS, Illumina Human BodyMap, and CGAP SAGE, Sets of similar genes according to GeneDecks, in vivo and in vitro expression data from LifeMap Discovery™, Protein expression images according to data from SPIRE 1MOPED, 2PaxDb, and 3MaxQB, plus additional links to SOURCE, and/or BioGPS, and/or UniProtKB,
    PCR Arrays from QIAGEN, Primers from OriGene, and/or QIAGEN, In Situ Hybridization Assays from Advanced Cell Diagnostics)
    About This Section

    TryGeneCards Plus

    IDO1 expression in normal human tissues (normalized intensities)
    See probesets specificity/sensitivity at GeneAnnot
    About this imageBioGPS <intensity>2/3
    CGAP TAG: AGAAGATATA
    IDO1 Expression
    About this image


    IDO1 expression in embryonic tissues and stem cells    About this table
    Data from LifeMap, the Embryonic Development and Stem Cells Database
     selected tissues (see all 4) fully expand
     
     Inner Cell Mass (Early Embryonic Tissues)    fully expand to see all 4 entries
             Human embryonic stem cells (family)
     
     Testis (Reproductive System)
             Leydig Cells Testis Interstitium
     
     Brain (Nervous System)
             Striatum
     
     Placenta (Extraembryonic Tissues)
    IDO1 Protein expression data from MOPED1, PaxDb2 and MaxQB3    About this image

    IDO1 Protein Expression

    SOURCE GeneReport for Unigene cluster: Hs.840
        Pathway & Disease-focused RT2 Profiler PCR Arrays including IDO1: 
              Amino Acid Metabolism I in human mouse rat
              T-Cell Anergy & Immune Tolerance in human mouse rat

    Primer
    Products:
    OriGene qPCR primer pairs and template standards for IDO1
    OriGene qSTAR qPCR primer pairs in human, mouse for IDO1
    Pre-validated RT2 qPCR Primer Assay in human, mouse, rat IDO1
    QuantiTect SYBR Green Assays in human, mouse, rat IDO1
    QuantiFast Probe-based Assays in human, mouse, rat IDO1
    In Situ
    Assay Products:
     

     
    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for IDO1

    (Orthologs according to 1,2HomoloGene (2older version, for species not in 1newer version), 3euGenes, 4SGD , 5MGI Mar 06 2013, with possible further links to Flybase and/or WormBase, and/or 6Ensembl pan taxonomic compara , Gene Trees according to Ensembl and TreeFam)
    About This Section

    TryGeneCards Plus

    This gene was present in the common ancestor of animals and fungi.

    Orthologs for IDO1 gene from Selected species (see all 10)    About this table
    Organism Taxonomic
    classification
    Gene Description Human
    Similarity
    Orthology
    Type
    Details
    mouse
    (Mus musculus)
    Mammalia Ido11 , 5 indoleamine 2,3-dioxygenase 11, 5 72.24(n)1
    62.53(a)1
      8 (12.76 cM)5
    159301  NM_008324.11  NP_032350.11 
     245841365 
    baker's yeast
    (Saccharomyces cerevisiae)
    Saccharomycetes BNA2(YJR078W)4
    BNA21
    Putative tryptophan 2,3-dioxygenase or indoleamine more4
    BNA21
    45(n)1
    35.29(a)1
      10(578860-580221)4
    8535411, 4  NP_012612.31  NP_012612.14 


    ENSEMBL Gene Tree for IDO1 (if available)
    TreeFam Gene Tree for IDO1 (if available)

    (Paralogs according to 1HomoloGene,
    2Ensembl, and 3SIMAP, Pseudogenes according to 4Pseudogene.org Build 68)
    About This Section

    TryGeneCards Plus
    Paralogs for IDO1 gene
    IDO22  
    1 SIMAP similar gene for IDO1 using alignment to 6 protein entries:     I23O1_HUMAN (see all proteins):
    IDO2

    Find genes that share paralogs with IDO1           About GenesLikeMe



    (SNPs/Variants according to the 1NCBI SNP Database, 2Ensembl, 3PupaSUITE, 4UniProtKB, and DNA2.0, Linkage Disequilibrium by HapMap, Structural Variations(CNVs/InDels/Inversions) from the Database of Genomic Variants, Mutations from the Human Gene Mutation Database (HGMD), the Human Cytochrome P450 Allele Nomenclature Database, and the Locus Specific Mutation Databases (LSDB), Blood group antigen gene mutations by BGMUT, Resequencing Primers, Cancer Mutation PCR Arrays and Assays, and Copy Number PCR Arrays from QIAGEN)
    About This Section

    TryGeneCards Plus

    Selected SNPs for IDO1 (see all 398)    About this table                                 

    Genomic DataTranscription Related DataAllele Frequencies
    SNP IDValidClinical
    significance
    Chr 8 posSequence#AA
    Chg
    TypeMore#Allele
    freq
    PopTotal
    sample
    More
    ----------
    rs726439041,2
    C,F--39773846(+) CAAAAA/CAAAAT 1 -- int11Minor allele frequency- C:0.03NA 120
    rs1129234211,2
    F--39773860(+) CCAGCA/GTGTTG 1 -- int12Minor allele frequency- G:0.04CSA WA 119
    rs113375171,2
    C,F--39780923(+) AAAAAA/-AAAAA 1 -- int1 trp32Minor allele frequency- -:0.50NA 4
    rs671169791,2
    C--39780923(+) GTCTC-/AAAAAAA 1 -- int10--------
    rs788791671,2
    C--39781630(+) ATCTG-/CCCTAC 1 -- int10--------
    rs748931141,2
    F--39784436(+) TAACTC/TCCACT 1 -- int11Minor allele frequency- T:0.06WA 118
    rs1148016331,2
    F--39840440(+) AGAGCA/CAAACG 1 -- us2k11Minor allele frequency- C:0.05WA 118
    rs38086061,2
    C,F,A,H--39840481(-) CAGGTC/TGTTAT 1 -- us2k124Minor allele frequency- T:0.41NA NS EA WA CSA 1667
    rs1442505061,2
    C--39840591(+) TGTAG-/GTAGTATG 1 -- cds10--------
    rs1444668831,2
    --39840611(+) AATCAA/TGGTGA 1 -- us2k10--------

    HapMap Linkage Disequilibrium report for IDO1 (39759794 - 39786309 bp)

    Structural Variations
         Database of Genomic Variants (DGV) 2 variations for IDO1:    About this table    
    Variant IDTypeSubtypePubMed ID
    esv2658388CNV Deletion23128226
    nsv508505CNV Loss20534489

    Human Gene Mutation Database (HGMD): IDO1
    Site Specific Mutation Identification with PCR Assays
    SeqTarget long-range PCR primers for resequencing IDO1
    DNA2.0 Custom Variant and Variant Library Synthesis for IDO1

    (in which this Gene is Involved, According to MalaCards, OMIM, UniProtKB, the University of Copenhagen DISEASES database, Novoseek, Genatlas, GeneTests, GAD, HuGE Navigator, and/or TGDB.)
    About This Section

    TryGeneCards Plus
    OMIM gene information: 147435    OMIM disorders: --

    10 diseases for IDO1:    
    About MalaCards
    toxic oil syndrome    listeriosis    trachoma    mediterranean spotted fever
    bladder disease    eosinophilia-myalgia syndrome    toxoplasmosis    typhus
    scrub typhus    malaria

    2 diseases from the University of Copenhagen DISEASES database for IDO1:
    eosinophilia-myalgia syndrome     Cancer

    Find genes that share disorders with IDO1           About GenesLikeMe

    Selected Novoseek inferred disease relationships for IDO1 gene (see all 73)    About this table

    Disease   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    bladder diseases 47.9 1 17537219 (1)
    inflammation 42.6 34 19155537 (3), 18547472 (2), 18036645 (2), 18063923 (2) (see all 26)
    tumors 42 216 14678522 (7), 19434461 (7), 2116480 (6), 18056175 (6) (see all 87)
    infection chronic 39.1 5 17876564 (1), 17671174 (1), 17767193 (1), 19007906 (1) (see all 5)
    autoimmune diseases 39 9 17430113 (3), 19494274 (1), 15206723 (1), 18660704 (1) (see all 7)
    toxoplasmosis cerebral 37.1 1 8617321 (1)
    necrosis 35.4 27 19935463 (2), 10805371 (1), 15516717 (1), 17457312 (1) (see all 22)
    nuclear cataract 35.2 1 16897708 (1)
    immunodeficiency 34.1 9 16139256 (1), 17626075 (1), 16902147 (1), 17430111 (1) (see all 8)
    autoimmunity 33.5 7 16476191 (1), 19023117 (1), 17360980 (1), 17767193 (1) (see all 5)

    Genetic Association Database (GAD): IDO1
    Human Genome Epidemiology (HuGE) Navigator: IDO1 (5 documents)

    Export disorders for IDO1 gene to outside databases

    (in PubMed. Associations of this gene to articles via 1Entrez Gene, 2UniProtKB/Swiss-Prot, 3HGNC, 4GAD, 5PharmGKB, 6HMDB, 7DrugBank, 8UniProtKB/TrEMBL, 9 Novoseek, and/or 10fRNAdb)
    About This Section

    TryGeneCards Plus

    PubMed articles for IDO1 gene, integrated from 10 sources (see all 674) (see top 10):
    (articles sorted by number of sources associating them with IDO1)
        Utopia: connect your pdf to the dynamic
    world of online information

    1. Molecular cloning, sequencing and expression of human interferon- gamma-inducible indoleamine 2,3-dioxygenase cDNA. (PubMed id 2109605)1, 2, 3 Dai W. and Gupta S.L. (Biochem. Biophys. Res. Commun. 1990)
    2. Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients. (PubMed id 16842443)1, 7, 9 Cozzi A....Moroni F. (J. Viral Hepat. 2006)
    3. Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase. (PubMed id 16477023)1, 2, 9 Sugimoto H.... Shiro Y. (Proc. Natl. Acad. Sci. U.S.A. 2006)
    4. Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus. (PubMed id 20331378)1, 4 Mosbruger T.L....Thio C.L. (J. Infect. Dis. 2010)
    5. Genetic variation in the indoleamine 2,3-dioxygenase gene in pre-eclampsia. (PubMed id 20192952)1, 4 Nishizawa H....Udagawa Y. (Am. J. Reprod. Immunol. 2010)
    6. Human variation in alcohol response is influenced by variation in neuronal signaling genes. (PubMed id 20201926)1, 4 Joslyn G....White R.L. (Alcohol. Clin. Exp. Res. 2010)
    7. Genetic polymorphisms, their allele combinations and IFN-beta treatment response in Irish multiple sclerosis patients. (PubMed id 19604093)1, 4 O'Doherty C....Vandenbroeck K. (Pharmacogenomics 2009)
    8. Evolution of vertebrate indoleamine 2,3-dioxygenases. (PubMed id 18026683)1, 2 Yuasa H.J.... Suzuki T. (J. Mol. Evol. 2007)
    9. Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase. (PubMed id 15636586)6, 7 Ferry G....Boutin J.A. (Biochem. J. 2005)
    10. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). (PubMed id 15489334)1, 2 Gerhard D.S.... Malek J. (Genome Res. 2004)
    11. Localization of indoleamine 2,3-dioxygenase gene (INDO) to chromosome 8p12--&gt;p11 by fluorescent in situ hybridization. (PubMed id 8404046)1, 3 Najfeld V....Gupta S.L. (Cytogenet. Cell Genet. 1993)
    12. Gene structure of human indoleamine 2,3-dioxygenase. (PubMed id 1449503)1, 2 Kadoya A.... Kido R. (Biochem. Biophys. Res. Commun. 1992)
    13. Primary structure of human indoleamine 2,3-dioxygenase deduced from the nucleotide sequence of its cDNA. (PubMed id 2326172)1, 2 Tone S....Kido R. (Nucleic Acids Res. 1990)
    14. IDO inhibits T-cell function through suppressing Vav1 expression and activation. (PubMed id 19597340)1, 9 Li R....Hao X. (amp 2009)
    15. Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand poly(I:C): mechanism of induction and role in antiviral response. (PubMed id 17626075)1, 9 Suh H.S....Lee S.C. (J. Virol. 2007)
    16. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. (PubMed id 19155537)1, 9 Schefold J.C....Reinke P. (Nephrol. Dial. Transplant. 2009)
    17. Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer. (PubMed id 19604349)1, 9 Mansfield A.S....Leidenius M.H. (BMC Cancer 2009)
    18. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer. (PubMed id 19487045)1, 9 Suzuki Y....Chida K. (Lung Cancer 2010)
    19. The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer. (PubMed id 19695096)1, 9 Gao Y.F....Zhang X.S. (J Transl Med 2009)
    20. Imaging correlates of differential expression of indoleamine 2,3-dioxygenase in human brain tumors. (PubMed id 19434461)1, 9 Batista C.E....Chugani D.C. (Mol Imaging Biol 2009)
    21. Indoleamine-dioxygenase is expressed in human decidua at the time maternal tolerance is established. (PubMed id 17321596)1, 9 von Rango U....Classen-Linke I. (J. Reprod. Immunol. 2007)
    22. Der p 1 suppresses indoleamine 2, 3-dioxygenase in dendritic cells from house dust mite-sensitive patients with asthma. (PubMed id 19058839)1, 9 Maneechotesuwan K....Wongkajornsilp A. (J. Allergy Clin. Immunol. 2009)
    23. Cytochrome b5, not superoxide anion radical, is a major reductant of indoleamine 2,3-dioxygenase in human cells. (PubMed id 18299324)1, 9 Maghzal G.J....Stocker R. (J. Biol. Chem. 2008)
    24. Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma. (PubMed id 18438685)1, 9 Pan K....Xia J.C. (J. Cancer Res. Clin. Oncol. 2008)
    25. Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. (PubMed id 16686756)1, 9 Beutelspacher S.C....George A.J. (Am. J. Transplant. 2006)
    26. Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase. (PubMed id 15102781)1, 9 Hucke C....DAoubener W. (Infect. Immun. 2004)
    27. Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta. (PubMed id 11912287)1, 9 Sedlmayr P....Dohr G. (Mol. Hum. Reprod. 2002)
    28. Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival. (PubMed id 19448397)1, 9 Brody J.R....Witkiewicz A.K. (Cell Cycle 2009)
    29. Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. (PubMed id 17433037)1, 9 Nakamura T....Saito S. (Cancer Sci. 2007)
    30. Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase. (PubMed id 16319139)1, 9 Hill M....Anegon I. (FASEB J. 2005)
    31. Reduced uterine indoleamine 2,3-dioxygenase versus increased Th1/Th2 cytokine ratios as a basis for occult and clinical pregnancy failure in mice and humans. (PubMed id 16135011)1, 9 Clark D.A....Arck P.C. (Am. J. Reprod. Immunol. 2005)
    32. Indoleamine 2,3-dioxygenase: antioxidant enzyme in the human eye. (PubMed id 8817290)1, 9 Malina H.Z. and Martin X.D. (Graefes Arch. Clin. Exp. Ophthalmol. 1996)
    33. Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance. (PubMed id 19933867)1, 9 Godin-Ethier J....Lapointe R. (J. Immunol. 2009)
    34. Hemoglobin induces the expression of indoleamine 2,3-dioxygenase in dendritic cells through the activation of PI3K, PKC, and NF-kappaB and the generation of reactive oxygen species. (PubMed id 19693771)1, 9 Ogasawara N....Nagase F. (J. Cell. Biochem. 2009)
    35. Post-translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide. (PubMed id 17535808)1, 9 Thomas S.R....Stocker R. (J. Biol. Chem. 2007)
    36. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. (PubMed id 15711557)1, 9 Muller A.J....Prendergast G.C. (Nat. Med. 2005)
    37. 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity. (PubMed id 16887964)7, 9 AgauguAc S....Lotteau V. (J. Immunol. 2006)
    38. Interactions between nitric oxide and indoleamine 2,3-dioxygenase. (PubMed id 16834326)1, 9 Samelson-Jones B.J. and Yeh S.R. (Biochemistry 2006)
    39. Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: implications for role of the kynurenine pathway in pregnancy. (PubMed id 15950064)1, 9 Ligam P....Walker D. (Placenta 2005)
    40. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. (PubMed id 14502282)1, 9 Uyttenhove C....Van den Eynde B.J. (Nat. Med. 2003)
    41. The role of indoleamine 2,3-dioxygenase in retinal pigment epithelial cell-mediated immune modulation. (PubMed id 20128646)1, 9 Park C.Y....Park C.G. (Ocul. Immunol. Inflamm. 2010)
    42. Indoleamine 2,3-dioxygenase in lung allograft tolerance. (PubMed id 19783182)1, 9 Meloni F....Fietta A.M. (J. Heart Lung Transplant. 2009)
    43. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. (PubMed id 19363598)1, 9 Wang S....Ning G. (Endocrine 2009)
    44. Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma. (PubMed id 18639339)1, 9 Corm S....Quesnel B. (Leuk. Res. 2009)
    45. Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study. (PubMed id 18622801)1, 9 Niinisalo P....Hurme M. (Scand. J. Clin. Lab. Invest. 2008)
    46. Differential immunosuppressive effect of indoleamine 2,3-dioxygenase (IDO) on primary human CD4+ and CD8+ T cells. (PubMed id 18008147)1, 9 Forouzandeh F....Ghahary A. (Mol. Cell. Biochem. 2008)
    47. Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation? (PubMed id 18055547)1, 9 Scheler M....von Bubnoff D. (Am. J. Pathol. 2007)
    48. Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human islets. (PubMed id 17192467)1, 9 Sarkar S.A....Hutton J.C. (Diabetes 2007)
    49. Indoleamine 2, 3-dioxygenase expression in cells of human acute monocyte leukemia (M(5)) and acute lymphocyte leukemia and therapeutic effect of its inhibitor 1-methyl tryptophan. (PubMed id 17605849)1, 9 Sun J.X....Liu S.H. (Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007)
    50. Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality. (PubMed id 16513157)1, 9 Pertovaara M....Hurme M. (Mech. Ageing Dev. 2006)
    51. Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. (PubMed id 15528322)1, 9 Odemuyiwa S.O....Moqbel R. (J. Immunol. 2004)
    52. Human epidermal langerhans cells express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. (PubMed id 15245429)1, 9 von Bubnoff D....de la Salle H. (J. Invest. Dermatol. 2004)
    53. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. (PubMed id 15001472)1, 9 Meisel R....Dilloo D. (Blood 2004)
    54. Inhibition of indoleamine 2,3-dioxygenase activity in IFN-gamma stimulated astroglioma cells decreases intracellular NAD levels. (PubMed id 12963490)1, 9 Grant R. and Kapoor V. (Biochem. Pharmacol. 2003)
    55. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. (PubMed id 20484731)1, 9 Favre D....McCune J.M. (Sci Transl Med 2010)
    56. Increased activity of indoleamine 2,3-dioxygenase in serum from acutely infected dengue patients linked to gamma interferon antiviral function. (PubMed id 19264674)1, 9 Becerra A....Bosch I. (J. Gen. Virol. 2009)
    57. Thymic indoleamine 2,3-dioxygenase-positive eosinophils in young children: potential role in maturation of the naive immune system. (PubMed id 19815714)1, 9 Tulic M.K....Moqbel R. (Am. J. Pathol. 2009)
    58. Localization of indoleamine 2,3-dioxygenase in human esophageal squamous cell carcinomas. (PubMed id 19844741)1, 9 Liu J....Cui G. (Virchows Arch. 2009)
    59. Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase. (PubMed id 19290871)7, 9 Rafice S.A....Raven E.L. (Biochem. Soc. Trans. 2009)
    60. Clinical relevance of indoleamine 2,3-dioxygenase for alloimmunity and transplantation. (PubMed id 18660700)1, 9 Brandacher G....Fuchs D. (Curr Opin Organ Transplant 2008)
    61. Indoleamine 2,3-dioxygenase expression in gestational trophoblastic disease: implications for development of immunotherapeutic approaches. (PubMed id 19004406)1, 9 Sebire N.J....Seckl M. (J Reprod Med 2008)
    62. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. (PubMed id 18832696)1, 9 Chen W....Blazar B.R. (J. Immunol. 2008)
    63. Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids. (PubMed id 18036645)1, 9 Maneechotesuwan K....Barnes P.J. (J. Allergy Clin. Immunol. 2008)
    64. Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells. (PubMed id 18045970)1, 9 Lob S....Terness P. (Blood 2008)
    65. [Indoleamine 2,3-dioxygenase expression in breast cancer patients during chemotherapy]. (PubMed id 19106591)1, 9 Sakurai K....Shiono M. (amp 2008)
    66. Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model. (PubMed id 19010841)1, 9 Yoshida N....Kikkawa F. (Clin. Cancer Res. 2008)
    67. The role of serine 167 in human indoleamine 2,3-dioxygenase: a comparison with tryptophan 2,3-dioxygenase. (PubMed id 18370410)1, 9 Chauhan N....Raven E.L. (Biochemistry 2008)
    68. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. (PubMed id 17158233)1, 9 Boasso A....Shearer G.M. (Blood 2007)
    69. On watching the watchers: IDO and type I/II IFN. (PubMed id 17393386)1, 9 Puccetti P. (Eur. J. Immunol. 2007)
    70. Tryptophan catabolism in IDO+ plasmacytoid dendritic cells. (PubMed id 17430109)7, 9 Fallarino F....Puccetti P. (Curr. Drug Metab. 2007)
    71. Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses? (PubMed id 17318080)1, 9 LAPb S....KAPnigsrainer A. (Transplantation 2007)
    72. IL-8 and IDO expression by human gingival fibroblasts via TLRs. (PubMed id 17202379)1, 9 Mahanonda R....Pichyangkul S. (J. Immunol. 2007)
    73. Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection. (PubMed id 17229698)1, 9 Larrea E....Prieto J. (J. Virol. 2007)
    74. Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-gamma contributes to medial immunoprivilege. (PubMed id 17911610)1, 9 Cuffy M.C....Tellides G. (J. Immunol. 2007)
    75. Intralesional expression of mRNA of interferon- gamma , tumor necrosis factor- alpha , interleukin-10, nitric oxide synthase, indoleamine-2,3-dioxygenase, and RANTES is a major immune effector in Mediterranean spotted fever rickettsiosis. (PubMed id 17674321)1, 9 de Sousa R....Walker D.H. (J. Infect. Dis. 2007)
    76. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. (PubMed id 17671174)2, 9 Metz R....Prendergast G.C. (Cancer Res. 2007)
    77. A putative mechanism on remission of multiple sclerosis during pregnancy: estrogen-induced indoleamine 2,3-dioxygenase by dendritic cells. (PubMed id 17294609)1, 9 Zhu W.H....Xiao B.G. (Mult. Scler. 2007)
    78. Crystallization and preliminary crystallographic studies of human indoleamine 2,3-dioxygenase. (PubMed id 16511306)1, 9 Oda S....Shiro Y. (Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2006)
    79. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. (PubMed id 16489067)1, 9 Brandacher G....Amberger A. (Clin. Cancer Res. 2006)
    80. Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer. (PubMed id 15967116)1, 9 Astigiano S....Frumento G. (Neoplasia 2005)
    81. Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon. (PubMed id 15919929)1, 9 Obojes K....Schneider-Schaulies J. (J. Virol. 2005)
    82. IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion. (PubMed id 16421220)1, 9 Miwa N....Saito S. (Mol. Hum. Reprod. 2005)
    83. Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indoleamine 2,3-dioxygenase. (PubMed id 15374002)1, 9 Adams O....DAoubener W. (Microbes Infect. 2004)
    84. Indoleamine 2,3-dioxygenase is necessary for cytolytic activity of natural killer cells. (PubMed id 14871294)1, 9 Kai S....Kitano S. (Scand. J. Immunol. 2004)
    85. Asp274 and his346 are essential for heme binding and catalytic function of human indoleamine 2,3-dioxygenase. (PubMed id 12766158)1, 9 Littlejohn T.K....Walker M.J. (J. Biol. Chem. 2003)
    86. Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alpha. (PubMed id 13678429)1, 9 Robinson C.M....Carlin J.M. (amp 2003)
    87. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. (PubMed id 12186837)1, 9 Terness P....Opelz G. (J. Exp. Med. 2002)
    88. Indoleamine 2,3-dioxygenase in the human lens, the first enzyme in the synthesis of UV filters. (PubMed id 11180976)1, 9 Takikawa O....Truscott R.J. (Exp. Eye Res. 2001)
    89. Localization of the human indoleamine 2,3-dioxygenase (IDO) gene to the pericentromeric region of human chromosome 8. (PubMed id 8406467)1, 9 Burkin D.J....Gupta S.L. (Genomics 1993)
    90. The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells. (PubMed id 24391212)1 Trabanelli S....Lemoli R.M. (J. Immunol. 2014)
    91. Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+ Treg impairment in systemic sclerosis. (PubMed id 23200754)1 Tardito S....Filaci G. (Hum. Immunol. 2013)
    92. Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia. (PubMed id 22936460)1 Catani L....Lemoli R.M. (Ann. Hematol. 2013)
    93. Mutation of cysteine residues alters the heme-binding pocket of indoleamine 2,3-dioxygenase-1. (PubMed id 23751345)1 Austin C.J....Jamie J.F. (Biochem. Biophys. Res. Commun. 2013)
    94. Mesoangioblasts suppress T cell proliferation through IDO and PGE-2-dependent pathways. (PubMed id 22913669)1 English K....Wood K.J. (Stem Cells Dev. 2013)
    95. Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4. (PubMed id 23752227)1 Holmgaard R.B....Allison J.P. (J. Exp. Med. 2013)
    96. Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma. (PubMed id 23179760)1 Ye J....Li Y. (Virchows Arch. 2013)
    97. Serum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney disease. (PubMed id 23651343)1 Bao Y.S....Na S.P. (Biomarkers 2013)
    98. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation. (PubMed id 22828446)1 Mougiakakos D....Le Blanc K. (Leukemia 2013)
    99. B7 costimulation and intracellular indoleamine-2,3-dioxygenase expression in peripheral blood of healthy pregnant and pre-eclamptic women. (PubMed id 23289444)1 Toldi G....Molvarec A. (Am. J. Reprod. Immunol. 2013)
    100. Indoleamine 2,3-dioxygenase-1 (IDO1) enhances survival and invasiveness of endometrial stromal cells via the activation of JNK signaling pathway. (PubMed id 23411497)1 Mei J....Zhu X.Y. (Int J Clin Exp Pathol 2013)
    101. IDO1 metabolites activate I^-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice. (PubMed id 23669411)1 Thaker A.I....Ciorba M.A. (Gastroenterology 2013)
    102. In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1. (PubMed id 23358471)1 Zitron I.M....Mittal S. (amp 2013)
    103. Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients. (PubMed id 23620105)1 Sioud M....Kvalheim G. (Int. J. Oncol. 2013)
    104. Indoleamine 2,3-dioxygenase levels at the normal and recurrent spontaneous abortion fetal-maternal interface. (PubMed id 23847296)1 Ban Y....Qu X. (J. Int. Med. Res. 2013)
    105. Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells. (PubMed id 23973990)1 Iachininoto M.G....Rutella S. (Molecules 2013)
    106. Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas. (PubMed id 23426156)1 Mitsuka K....Kinouchi H. (Neurosurgery 2013)
    107. Human indoleamine 2,3-dioxygenase is a catalyst of physiological heme peroxidase reactions: implications for the inhibition of dioxygenase activity by hydrogen peroxide. (PubMed id 23209301)1 Freewan M....Thomas S.R. (J. Biol. Chem. 2013)
    108. Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry. (PubMed id 23344392)1 Soliman H....Ambs S. (Cancer Immunol. Immunother. 2013)
    109. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. (PubMed id 23440412)1 Yu J....Ren X. (J. Immunol. 2013)
    110. IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis. (PubMed id 23853597)1 De Luca A....Romani L. (PLoS Pathog. 2013)
    111. Activated CD69+ T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages. (PubMed id 22184722)1 Zhao Q....Zheng L. (J. Immunol. 2012)
    112. Inhibition of IDO1 suppresses cyclooxygenase-2 and matrix metalloproteinase-9 expression and decreases proliferation, adhesion and invasion of endometrial stromal cells. (PubMed id 22638210)1 Mei J....Zhu X.Y. (Mol. Hum. Reprod. 2012)
    113. High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma. (PubMed id 21328335)1 Jacquemier J....Xerri L. (Int. J. Cancer 2012)
    114. Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-I+-induced depression in patients with chronic hepatitis C. (PubMed id 21691274)1 Smith A.K....Miller A.H. (Mol. Psychiatry 2012)
    115. Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation. (PubMed id 22923135)1 Sato N....Suzuki M. (Oncol. Rep. 2012)
    116. Flavivirus infection induces indoleamine 2,3-dioxygenase in human monocyte-derived macrophages via tumor necrosis factor and NF-I_B. (PubMed id 22301793)1 Yeung A.W....Thomas S.R. (J. Leukoc. Biol. 2012)
    117. Indoleamine 2,3-dioxygenase activation and depressive symptoms: results from the Young Finns Study. (PubMed id 22929065)1 Elovainio M....Keltikangas-JAorvinen L. (Psychosom Med 2012)
    118. Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma. (PubMed id 23232072)1 Bonanno G....Rutella S. (J Transl Med 2012)
    119. The cystine/glutamate antiporter regulates the functional expression of indoleamine 2,3-dioxygenase in human dendritic cells. (PubMed id 22690871)1 D'Angelo J.A....Dickinson B.L. (Scand. J. Immunol. 2012)
    120. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia. (PubMed id 22526360)1 Xu S.Q....Hou M. (Ann. Hematol. 2012)
    121. Indole peroxygenase activity of indoleamine 2,3-dioxygenase. (PubMed id 22891315)1 Kuo H.H. and Mauk A.G. (Proc. Natl. Acad. Sci. U.S.A. 2012)
    122. IDO in human gut graft-versus-host disease. (PubMed id 21835147)1 Ratajczak P....SociAc G. (Biol. Blood Marrow Transplant. 2012)
    123. Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone. (PubMed id 22592557)1 Wolowczuk I....Poulain-Godefroy O. (Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012)
    124. An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-I^: potential therapeutic use in autoimmune diseases. (PubMed id 22424783)1 Xue Z.T....Widegren B. (Mol. Immunol. 2012)
    125. A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins. (PubMed id 22069308)1 Diegelmann J....Brand S. (J. Biol. Chem. 2012)
    126. Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. (PubMed id 22751107)1 Kim H....Mao J. (J. Clin. Invest. 2012)
    127. IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival. (PubMed id 22932670)1 Wainwright D.A....Lesniak M.S. (Clin. Cancer Res. 2012)
    128. Indoleamine 2,3-dioxygenase expression and functional activity in dendritic cells exposed to cholera toxin. (PubMed id 22519828)1 Slavica L....Eriksson K. (Scand. J. Immunol. 2012)
    129. Indoleamine 2,3-dioxygenase expression and serum kynurenine concentrations in patients with diffuse large B-cell lymphoma. (PubMed id 22112045)1 Ninomiya S....Moriwaki H. (amp 2012)
    130. Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity. (PubMed id 21823214)1 Gupta N.K....Ciorba M.A. (Inflamm. Bowel Dis. 2012)
    131. Activation of indoleamine 2,3-dioxygenase in patients with scrub typhus and its role in growth restriction of Orientia tsutsugamushi. (PubMed id 22860140)1 Prachason T....Limwongse C. (PLoS Negl Trop Dis 2012)
    132. Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growth. (PubMed id 22722711)1 Pfeifer S....Zojer N. (J. Cancer Res. Clin. Oncol. 2012)
    133. Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth. (PubMed id 23090116)1 Blache C.A....Diamond D.J. (Cancer Res. 2012)
    134. Induction of regulatory T Cells by dendritic cells through indoleamine 2,3-dioxygenase: a potent mechanism of acquired peripheral tolerance. (PubMed id 21517756)1 Trabanelli S....Curti A. (Curr. Med. Chem. 2011)
    135. Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity. (PubMed id 21712776)1 Maes M....Rief W. (Neuro Endocrinol. Lett. 2011)
    136. IDO induces expression of a novel tryptophan transporter in mouse and human tumor cells. (PubMed id 21742973)1 Silk J.D....Cerundolo V. (J. Immunol. 2011)
    137. Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP. (PubMed id 20938662)1 Ninomiya S....Moriwaki H. (Ann. Hematol. 2011)
    138. The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression. (PubMed id 21592112)1 de Souza Sales J....Sarno E.N. (Clin. Exp. Immunol. 2011)
    139. Regulation of expression and function of IDO in human dendritic cells. (PubMed id 21517757)1 Heitger A. (Curr. Med. Chem. 2011)
    140. Vascular endothelial expression of indoleamine 2,3-dioxygenase 1 forms a positive gradient towards the feto-maternal interface. (PubMed id 21755000)1 Blaschitz A....Sedlmayr P. (PLoS ONE 2011)
    141. Reduced expression of indoleamine 2,3-dioxygenase participates in pathogenesis of preeclampsia via regulatory T cells. (PubMed id 21461563)1 Liu X....Wang X. (Mol Med Rep 2011)
    142. Ferryl derivatives of human indoleamine 2,3-dioxygenase. (PubMed id 21502325)1 Lu C. and Yeh S.R. (J. Biol. Chem. 2011)
    143. Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination. (PubMed id 21292009)1 Eleftheriadis T....Galaktidou G. (Vaccine 2011)
    144. Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases. (PubMed id 21517753)1 Prendergast G.C....Muller A.J. (Curr. Med. Chem. 2011)
    145. Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin. (PubMed id 21118329)1 Anderson G. and Rodriguez M. (Eur. J. Neurol. 2011)
    146. Decreased IDO activity and increased TTS expression break immune tolerance in patients with immune thrombocytopenia. (PubMed id 21487895)1 Wang C.Y....Hou M. (J. Clin. Immunol. 2011)
    147. Immunoactivative role of indoleamine 2,3a89dioxygenase in gastric cancer cells in vitro. (PubMed id 21461581)1 Zhang R....Ren X. (Mol Med Rep 2011)
    148. Moderating effect of indoleamine 2,3-dioxygenase (IDO) activation in the association between depressive symptoms and carotid atherosclerosis: evidence from the Young Finns study. (PubMed id 21600662)1 Elovainio M....Keltikangas-JAorvinen L. (J Affect Disord 2011)
    149. Is the variant c.422+90G a89 A in intron 4 of indoleamine 2, 3 -dioxygenase (IDO) gene related to age related cataracts? (PubMed id 21617756)1 Mamata M....Padma T. (Mol. Vis. 2011)
    150. Myeloid CD11c+ S100+ dendritic cells express indoleamine 2,3-dioxygenase at the inflammatory border to invasive lower lip squamous cell carcinoma. (PubMed id 21692032)1 Kuales M.A....von Bubnoff D. (Histol. Histopathol. 2011)
    151. Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein. (PubMed id 21832049)1 OlA!h J....OvA!di J. (J. Biol. Chem. 2011)
    152. Toll-like receptor-3 ligation-induced indoleamine 2, 3-dioxygenase expression in human trophoblasts. (PubMed id 21952237)1 Wang B....Taketani Y. (Endocrinology 2011)
    153. Coding region polymorphisms in the indoleamine 2,3-dioxygenase (INDO) gene and recurrent spontaneous abortion. (PubMed id 21030093)1 Amani D....Ghaderi A. (J. Reprod. Immunol. 2011)
    154. [An experimental study on the regulation of bone marrow-derived mesenchymal stem cells through indoleamine 2,3-dioxygenase signaling pathway by thymosin I+1 for improving the immunosuppression mediated by T cell]. (PubMed id 21575365)1 Hou F....Li G. (Zhonghua Er Ke Za Zhi 2011)
    155. The mechanism of formation of N-formylkynurenine by heme dioxygenases. (PubMed id 21892828)1 Basran J....Raven E.L. (J. Am. Chem. Soc. 2011)
    156. The interplay between indoleamine 2,3-dioxygenase 1 (IDO1) and cyclooxygenase (COX)-2 in chronic inflammation and cancer. (PubMed id 21517752)1 Cesario A....Rutella S. (Curr. Med. Chem. 2011)
    157. Potential immunosuppressive function of plasma indoleamine 2,3-dioxygenase in patients with aGVHD after allo-HSCT. (PubMed id 21355883)1 Zhao X.S....Huang X.J. (Clin Transplant 2011)
    158. Indoleamine 2,3-dioxygenase, Tregs and cancer. (PubMed id 21517755)1 Munn D.H. (Curr. Med. Chem. 2011)
    159. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C. (PubMed id 21693183)1 GalvALo-de Almeida A....Guindalini C. (Brain Behav. Immun. 2011)
    160. Tryptophan catabolism is associated with acute GVHD after human allogeneic stem cell transplantation and indicates activation of indoleamine 2,3-dioxygenase. (PubMed id 22039265)1 Landfried K....Holler E. (Blood 2011)
    161. Genome-wide YFP fluorescence complementation screen identifies new regulators for telomere signaling in human cells. (PubMed id 21044950)1 Lee O.H....Songyang Z. (amp 2011)
    162. Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors. (PubMed id 21835273)1 Meininger D....Sutherland C.L. (Biochim. Biophys. Acta 2011)
    163. Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma. (PubMed id 22013481)1 Zhang G....Du J. (amp 2011)
    164. Identification of a variable number of tandem repeats polymorphism and characterization of LEF-1 response elements in the promoter of the IDO1 gene. (PubMed id 21980470)1 Soichot M....Allorge D. (PLoS ONE 2011)
    165. Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests. (PubMed id 21616522)1 Sznurkowski J.J....Biernat W. (Gynecol. Oncol. 2011)
    166. Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis. (PubMed id 22110525)1 Yu J....Ren X. (amp 2011)
    167. Indoleamine 2,3-dioxygenase-expressing myeloid dendritic cells and macrophages in infectious and noninfectious cutaneous granulomas. (PubMed id 21501890)1 von Bubnoff D....Wickenhauser C. (J. Am. Acad. Dermatol. 2011)
    168. Interferon-I^ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO). (PubMed id 21359206)1 Croitoru-Lamoury J....Brew B.J. (PLoS ONE 2011)
    169. Structure and reaction mechanism in the heme dioxygenases. (PubMed id 21361337)1 Efimov I....Raven E.L. (Biochemistry 2011)
    170. [Study of indoleamine 2,3-dioxygenase expression in patients of thyroid cancer]. (PubMed id 22202241)1 Sakurai K....Amano S. (amp 2011)
    171. [Expression of indoleamine 2, 3-dioxygenase and its correlation with prognosis in breast cancer patients]. (PubMed id 22093628)1 Liu J.T....Ren X.B. (Zhonghua Zhong Liu Za Zhi 2011)
    172. Effects of chronic ascariasis and trichuriasis on cytokine production and gene expression in human blood: a cross-sectional study. (PubMed id 21666788)1 Reina Ortiz M....Cooper P.J. (PLoS Negl Trop Dis 2011)
    173. NADH oxidase activity of indoleamine 2,3-dioxygenase. (PubMed id 21690092)1 Rosell F.I....Mauk A.G. (J. Biol. Chem. 2011)
    174. The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment. (PubMed id 21324164)1 Gold A.B....LanctA't K.L. (J Neuroinflammation 2011)
    175. The first step of the dioxygenation reaction carried out by tryptophan dioxygenase and indoleamine 2,3-dioxygenase as revealed by quantum mechanical/molecular mechanical studies. (PubMed id 20361220)1 Capece L....Marti M.A. (J. Biol. Inorg. Chem. 2010)
    176. Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans. (PubMed id 20689575)1 Kiank C....Schuett C. (PLoS ONE 2010)
    177. Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease. (PubMed id 20663292)1 Bonda D.J....Smith M.A. (Redox Rep. 2010)
    178. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO. (PubMed id 20386557)1 Tipnis S....Majumdar A.S. (Immunol. Cell Biol. 2010)
    179. Intact indoleamine 2,3-dioxygenase activity in human chronic granulomatous disease. (PubMed id 20570568)1 JA1rgens B....Heitger A. (Clin. Immunol. 2010)
    180. [Regulatory effect of thymosin I+1 on expression of tlr9/ido mRNA in bone marrow mesenchymal stem cells from children with aplastic anemia]. (PubMed id 21176371)1 Hou F....Li G. (Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010)
    181. Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels. (PubMed id 20691806)1 Jiang G.M....Du J. (amp 2010)
    182. Beyond immunosuppression: reconsidering indoleamine 2,3-dioxygenase as a pathogenic element of chronic inflammation. (PubMed id 20635895)1 Muller A.J....Prendergast G.C. (Immunotherapy 2010)
    183. Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS. (PubMed id 20602605)1 Samikkannu T....Nair M.P. (J. Neurovirol. 2010)
    184. High levels of IDO-expressing CD16+ peripheral cells, and Tregs in graft biopsies from kidney transplant recipients under belatacept treatment. (PubMed id 21094802)1 Furuzawa-Carballeda J....AlberA_ J. (Transplant. Proc. 2010)
    185. Indoleamine 2,3-dioxygenase+ cells correspond to the BDCA2+ plasmacytoid dendritic cells in human melanoma sentinel nodes. (PubMed id 19829303)1 Gerlini G....Borgognoni L. (J. Invest. Dermatol. 2010)
    186. High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death. (PubMed id 20648630)1 Habibi D....Ghahary A. (J. Cell. Physiol. 2010)
    187. A specific interaction of L-tryptophan with CO of CO-bound indoleamine 2,3-dioxygenase identified by resonance Raman spectroscopy. (PubMed id 21028817)1 Yanagisawa S....Ogura T. (Biochemistry 2010)
    188. Local expression of indoleamine 2,3 dioxygenase in syngeneic fibroblasts significantly prolongs survival of an engineered three-dimensional islet allograft. (PubMed id 20522587)1 Jalili R.B....Ghahary A. (Diabetes 2010)
    189. Gene-expression profiles in human nasal polyp tissues and identification of genetic susceptibility in aspirin-intolerant asthma. (PubMed id 19489917)1 Sekigawa T....Inoue I. (Clin. Exp. Allergy 2009)
    190. Inhibitory substrate binding site of human indoleamine 2,3-dioxygenase. (PubMed id 19737010)1 Lu C....Yeh S.R. (J. Am. Chem. Soc. 2009)
    191. Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase. (PubMed id 19740345)1 Flatekval G.F. and Sioud M. (Immunology 2009)
    192. Free iron ions decrease indoleamine 2,3-dioxygenase expression and reduce IFNgamma-induced inhibition of Chlamydia trachomatis infection. (PubMed id 19306922)1 Krausse-Opatz B....KAPhler L. (Microb. Pathog. 2009)
    193. Identification of genetic variants in the human indoleamine 2,3-dioxygenase (IDO1) gene, which have altered enzyme activity. (PubMed id 19514129)1 Arefayene M....Skaar T.C. (Pharmacogenet. Genomics 2009)
    194. Indoleamine-2,3-dioxygenase enzyme expression and activity in polarized dendritic cells. (PubMed id 19929471)1 Wolf B....Ernstoff M.S. (Cytotherapy 2009)
    195. Mouse and human indoleamine 2,3-dioxygenase display some distinct biochemical and structural properties. (PubMed id 18274832)1 Austin C.J....Hunt N.H. (Amino Acids 2009)
    196. Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis. (PubMed id 19168733)1 Bourreau E....Launois P. (Infect. Immun. 2009)
    197. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R. (PubMed id 19353519)1 Opitz C.A....Platten M. (Stem Cells 2009)
    198. Amino acid deprivation links BLIMP-1 to the immunomodulatory enzyme indoleamine 2,3-dioxygenase. (PubMed id 19828629)1 Barnes N.A....Doody G.M. (J. Immunol. 2009)
    199. Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. (PubMed id 19465693)1 Chung D.J....Young J.W. (Blood 2009)
    200. Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression. (PubMed id 19564344)1 Liu H....Visner G.A. (J. Immunol. 2009)
    201. Immune regulation and tolerance to fungi in the lungs and skin. (PubMed id 18802343)1 Romani L. and Puccetti P. (Chem Immunol Allergy 2008)
    202. Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgamma. (PubMed id 19074858)1 Gasparri A.M....Corti A. (Mol. Cancer Ther. 2008)
    203. Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation. (PubMed id 18205804)1 Heseler K....DAoubener W. (FEMS Immunol. Med. Microbiol. 2008)
    204. High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome. (PubMed id 19050070)1 Chamuleau M.E....Ossenkoppele G.J. (Haematologica 2008)
    205. Impaired indoleamine 2,3-dioxygenase production contributes to the development of autoimmunity in primary biliary cirrhosis. (PubMed id 18176870)1 Oertelt-Prigione S....Gershwin M.E. (Autoimmunity 2008)
    206. Suppression of cytotoxic and proliferative xenogeneic T-cell responses by transgenic expression of indoleamine 2,3-dioxygenase. (PubMed id 18332894)1 Wee J.L....Sandrin M.S. (Immunol. Cell Biol. 2008)
    207. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. (PubMed id 17951526)1 Spaggiari G.M....Moretta L. (Blood 2008)
    208. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. (PubMed id 18776940)1 Manches O....Bhardwaj N. (J. Clin. Invest. 2008)
    209. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. (PubMed id 17417651)7 Grohmann U....Puccetti P. (Nat. Med. 2007)
    210. Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. (PubMed id 17170728)1 Curti A....Lemoli R.M. (Leukemia 2007)
    211. hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes. (PubMed id 17207965)1 Lamesch P.... Vidal M. (Genomics 2007)
    212. Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. (PubMed id 17376903)1 Campbell G.R....Spector S.A. (J. Virol. 2007)
    213. Upregulation of placental indoleamine 2,3-dioxygenase by human chorionic gonadotropin. (PubMed id 17182891)1 Lei Z.M....Rao C.V. (Biol. Reprod. 2007)
    214. Nonviral gene delivery with indoleamine 2,3-dioxygenase targeting pulmonary endothelium protects against ischemia-reperfusion injury. (PubMed id 17711549)1 Liu H....Visner G.A. (Am. J. Transplant. 2007)
    215. Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference. (PubMed id 17015752)7 Zheng X....Min W.P. (J. Immunol. 2006)
    216. Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis. (PubMed id 17015408)1 Liu H....Visner G.A. (FASEB J. 2006)
    217. Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. (PubMed id 16344560)1 Kimura K.... Sugano S. (Genome Res. 2006)
    218. The immunoregulatory role of IDO-producing human dendritic cells revisited. (PubMed id 16406698)1 Terness P....Opelz G. (Trends Immunol. 2006)
    219. Rabbit antithymocyte globulin inhibits monocyte-derived dendritic cells maturation in vitro and polarizes monocyte-derived dendritic cells towards tolerogenic dendritic cells expressing indoleamine 2,3-dioxygenase. (PubMed id 17038913)1 Gillet-Hladky S....Rigal D. (Transplantation 2006)
    220. A human protein-protein interaction network: a resource for annotating the proteome. (PubMed id 16169070)1 Stelzl U.... Wanker E.E. (Cell 2005)
    221. A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. (PubMed id 15947091)1 Braun D....Albert M.L. (Blood 2005)
    222. Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism. (PubMed id 16176799)1 Takikawa O. (Biochem. Biophys. Res. Commun. 2005)
    223. Complete sequencing and characterization of 21,243 full-length human cDNAs. (PubMed id 14702039)2 Ota T.... Sugano S. (Nat. Genet. 2004)
    224. Mechanisms regulating the expression of indoleamine 2,3-dioxygenase during decidualization of human endometrium. (PubMed id 15070879)1 Kudo Y....Ohama K. (Hum. Reprod. 2004)
    225. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. (PubMed id 15254595)1 Munn D.H....Mellor A.L. (J. Clin. Invest. 2004)
    226. Cell surface expression of MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftment. (PubMed id 14969766)1 Li Y....Ghahary A. (Hum. Immunol. 2004)
    227. Enzymology of NAD+ homeostasis in man. (PubMed id 14704851)1 Magni G....Ruggieri S. (Cell. Mol. Life Sci. 2004)
    228. Tolerance, DCs and tryptophan: much ado about IDO. (PubMed id 12738417)1 Grohmann U....Puccetti P. (Trends Immunol. 2003)
    229. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG). (PubMed id 12938169)1 Sarkhosh K....Ghahary A. (J. Cell. Biochem. 2003)
    230. The heme environment of recombinant human indoleamine 2,3-dioxygenase. Structural properties and substrate-ligand interactions. (PubMed id 11867636)1 Terentis A.C....Stocker R. (J. Biol. Chem. 2002)
    231. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. (PubMed id 12228717)1 Munn D.H....Mellor A.L. (Science 2002)
    232. TTD: Therapeutic Target Database. (PubMed id 11752352)7 Chen X....Chen Y.Z. (Nucleic Acids Res. 2002)
    233. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. (PubMed id 12477932)1 Strausberg R.L....Marra M.A. (Proc. Natl. Acad. Sci. U.S.A. 2002)
    234. Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells. (PubMed id 11876748)1 Kvirkvelia N....Delves P.J. (Clin. Exp. Immunol. 2002)
    235. HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. (PubMed id 12444143)1 Mirani M....Kino T. (J. Immunol. 2002)
    236. IFN-gamma amplifies IL-6 and IL-8 responses by airway epithelial-like cells via indoleamine 2,3-dioxygenase. (PubMed id 12471139)1 van Wissen M....Lutter R. (J. Immunol. 2002)
    237. Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases. (PubMed id 11987129)1 BarcelA^-Batllori S....Felley-Bosco E. (Proteomics 2002)
    238. The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants. (PubMed id 11230514)1 Kudo Y. and Boyd C.A. (J. Physiol. (Lond.) 2001)
    239. Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. (PubMed id 10737800)1 Dias Neto E....Simpson A.J.G. (Proc. Natl. Acad. Sci. U.S.A. 2000)
    240. Prevention of allogeneic fetal rejection by tryptophan catabolism. (PubMed id 9712583)1 Munn D.H....Mellor A.L. (Science 1998)
    241. Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta. (PubMed id 1716396)1 Kamimura S....Sekiba K. (Acta Med. Okayama 1991)
    242. Effects of tryptophan and pH on the kinetics of superoxide radical binding to indoleamine 2,3-dioxygenase studied by pulse radiolysis. (PubMed id 2549057)1 Kobayashi K....Sono M. (J. Biol. Chem. 1989)
    243. Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. (PubMed id 2482041)1 Werner-Felmayer G....Wachter H. (Biol. Chem. Hoppe-Seyler 1989)
    244. Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. (PubMed id 2501398)1 Carlin J.M....Byrne G.I. (J. Interferon Res. 1989)
    245. Pulmonary indoleamine 2,3-dioxygenase activity and its significance in the response of rats, mice, and rabbits to oxidative stress. (PubMed id 2848333)1 Daley-Yates P.T....Smith L.L. (Toxicol. Appl. Pharmacol. 1988)
    246. Inflamed intestinal mucosa features a specific epithelial expression pattern of indoleamine 2,3-dioxygenase. (PubMed id 18547472)9 Ferdinande L....Cuvelier C.A. (Int J Immunopathol Pharmacol 2008)
    247. Temperature-sensitive polymer-conjugated IFN-gamma induces the expression of IDO mRNA and activity by fibroblasts populated in collagen gel (FPCG). (PubMed id 15281097)9 Sarkhosh K....Ghahary A. (J. Cell. Physiol. 2004)
    248. Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality. (PubMed id 19828695)9 Jasperson L.K....Blazar B.R. (Blood 2009)
    249. Inhibition of indoleamine 2,3-dioxygenase suppresses NK cell activity and accelerates tumor growth. (PubMed id 14678522)9 Kai S....Kitano S. (amp 2003)
    250. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma. (PubMed id 12014674)9 Liebau C....Merk H. (Anticancer Res. 2002)
    251. Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes. (PubMed id 7553232)9 Hu B....Carlin J.M. (amp 1995)
    252. Indoleamine 2,3-dioxygenase expression and regulation in chronic periodontitis. (PubMed id 19228097)9 Nisapakultorn K....Takikawa O. (J. Periodontol. 2009)
    253. Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection. (PubMed id 18471709)9 Witkiewicz A....Brody J.R. (J. Am. Coll. Surg. 2008)
    254. Localization and spatiotemporal expression of IDO following transient forebrain ischemia in gerbils. (PubMed id 18501338)9 Taguchi A....Mori H. (Brain Res. 2008)
    255. Effect of Kidney-replenishing herb on the indoleamine 2,3-dioxygenase of human syncytiotrophoblasts cultured in vitro and the balance of helper T-cell cytokines. (PubMed id 17999277)9 Li X....Wang H. (Gynecol. Endocrinol. 2007)
    256. Bimodal effect of nitric oxide in the enzymatic activity of indoleamine 2,3-dioxygenase in human monocytic cells. (PubMed id 16797727)9 LA^pez A.S....GonzA!lez A. (Immunol. Lett. 2006)
    257. Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma. (PubMed id 14748880)9 Ishio T....Kitano S. (J. Gastroenterol. Hepatol. 2004)
    258. The role of tryptophan catabolism in acquisition and effector function of memory T cells. (PubMed id 18660704)9 Dai H. and Dai Z. (Curr Opin Organ Transplant 2008)
    259. Indoleamine 2,3-dioxygenase expression in patients with acute graft-versus-host disease after allogeneic stem cell transplantation and in pregnant women: association with the induction of allogeneic immune tolerance? (PubMed id 12588666)9 Steckel N.K....Elmaagacli A.H. (Scand. J. Immunol. 2003)
    260. Reversal of interferon-gamma-resistant phenotype by poly(I:C): possible involvement of ISGF2 (IRF1) in interferon-gamma-mediated induction of the IDO gene. (PubMed id 8027591)9 Ozes O.N. and Taylor M.W. (J. Interferon Res. 1994)
    261. Cloning and expression of a cDNA encoding mouse indoleamine 2,3-dioxygenase. (PubMed id 1937018)9 Habara-Ohkubo A....Yoshida R. (Gene 1991)
    262. Design of novel hypoxia-targeting IDO hybrid inhibitors conjugated with an unsubstituted L-TRP as an IDO affinity moiety. (PubMed id 20204824)9 Nakashima H....Hori H. (Adv. Exp. Med. Biol. 2010)
    263. Immunosuppressive effect of IDO on T cells in patients with chronic hepatitis B*. (PubMed id 19207575)9 Chen Y.B....Gong J.P. (Hepatol. Res. 2009)
    264. Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells. (PubMed id 17609291)9 Mohib K....Jevnikar A.M. (Am. J. Physiol. Renal Physiol. 2007)
    265. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion. (PubMed id 17870068)9 Chen P.W....Niederkorn J.Y. (Exp. Eye Res. 2007)
    266. Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer. (PubMed id 17487387)9 Takao M....Tanaka T. (Oncol. Rep. 2007)
    267. Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer. (PubMed id 17700060)9 Karanikas V....Germenis A.E. (amp 2007)
    268. Tumor necrosis factor-alpha and lipopolysaccharide enhance interferon-induced antichlamydial indoleamine dioxygenase activity independently. (PubMed id 10805371)9 Currier A.R....Carlin J.M. (amp 2000)
    269. Potentiation of interferon-induced indoleamine 2,3-dioxygenase mRNA in human mononuclear phagocytes by lipopolysaccharide and interleukin-1. (PubMed id 9243370)9 Hissong B.D. and Carlin J.M. (amp 1997)
    270. Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes. (PubMed id 7514170)9 Thomas S.R....Stocker R. (J. Biol. Chem. 1994)
    271. Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy. (PubMed id 20350764)9 Inaba T....Kikkawa F. (Gynecol. Oncol. 2010)
    272. Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma. (PubMed id 19802733)9 Urakawa H....Ishiguro N. (amp 2009)
    273. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. (PubMed id 18364004)9 Katz J.B....Prendergast G.C. (Immunol. Rev. 2008)
    274. Indoleamine 2,3-dioxygenase in transplantation. (PubMed id 18221253)9 Mulley W.R. and Nikolic-Paterson D.J. (Nephrology (Carlton) 2008)
    275. Expression of indoleamine 2,3-dioxygenase in the rhesus monkey and common marmoset. (PubMed id 18490060)9 Drenzek J.G....Golos T.G. (J. Reprod. Immunol. 2008)
    276. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging. (PubMed id 18077563)9 Oxenkrug G.F. (Ann. N. Y. Acad. Sci. 2007)
    277. IFN-gamma-induced IDO and WRS expression in microglia is differentially regulated by IL-4. (PubMed id 17661345)9 Yadav M.C....Fox H.S. (Glia 2007)
    278. Indoleamine 2,3-dioxygenase in immune suppression and cancer. (PubMed id 17305476)9 Muller A.J. and Prendergast G.C. (Curr Cancer Drug Targets 2007)
    279. [Preparation of anti-human indoleamine 2,3-dioxygenase polyclonal antibody]. (PubMed id 17355802)9 Xie B.L....Du J. (Ai Zheng 2007)
    280. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma. (PubMed id 18056175)9 Riesenberg R....Zimmermann W. (Clin. Cancer Res. 2007)
    281. Nitration and inactivation of IDO by peroxynitrite. (PubMed id 16365430)9 Fujigaki H....Markey S.P. (J. Immunol. 2006)
    282. A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. (PubMed id 16094019)9 Popat R....Dasgupta P. (J. Urol. 2005)
    283. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways. (PubMed id 16236119)9 Le Rond S....Rouas-Freiss N. (Immunology 2005)
    284. [Study of indoleamine 2,3-dioxygenase expression in patients of esophageal squamous cell carcinoma]. (PubMed id 15553713)9 Sakurai K....Negishi N. (amp 2004)
    285. Indoleamine 2,3-dioxygenase is regulated by IFN-gamma in the mouse placenta during Listeria monocytogenes infection. (PubMed id 12517946)9 Mackler A.M....Pollard J.W. (J. Immunol. 2003)
    286. Antioxidants inhibit indoleamine 2,3-dioxygenase in IFN-gamma-activated human macrophages: posttranslational regulation by pyrrolidine dithiocarbamate. (PubMed id 11342657)9 Thomas S.R....Stocker R. (J. Immunol. 2001)
    287. Interleukin-1 inhibits gamma interferon-induced bacteriostasis in human uroepithelial cells. (PubMed id 10531207)9 DAoubener W....MacKenzie C.R. (Infect. Immun. 1999)
    288. Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression. (PubMed id 9731757)9 Yuan W....Varga J. (J. Cell. Physiol. 1998)
    289. Potentiation of interferon-mediated inhibition of Chlamydia infection by interleukin-1 in human macrophage cultures. (PubMed id 7537250)9 Carlin J.M. and Weller J.B. (Infect. Immun. 1995)
    290. Cytokine-mediated indoleamine 2,3-dioxygenase induction in response to Chlamydia infection in human macrophage cultures. (PubMed id 8132317)9 Paguirigan A.M....Carlin J.M. (Infect. Immun. 1994)
    291. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. (PubMed id 8293279)9 Heyes M.P....Vickers J.H. (Brain 1993)
    292. Differential induction of indoleamine-2,3-dioxygenase (IDO) by interferon-gamma in human gynecologic cancer cells. (PubMed id 1451099)9 Leung B.S....Thompson R.M. (Cancer Lett. 1992)
    293. In vitro modulation of cytochrome P450 reductase supported indoleamine 2,3-dioxygenase activity by allosteric effectors cytochrome b(5) and methylene blue. (PubMed id 20178337)9 Pearson J.T....Rock D.A. (Biochemistry 2010)
    294. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. (PubMed id 20427394)9 Matteoli G....Rescigno M. (Gut 2010)
    295. Enhanced indoleamine 2,3-dioxygenase activity in patients with severe sepsis and septic shock. (PubMed id 20151841)9 Tattevin P....Tarte K. (J. Infect. Dis. 2010)
    296. Factors associated with choice of psychotropic drugs used for intentional drug overdose. (PubMed id 18806918)9 Tournier M....Verdoux H. (Eur Arch Psychiatry Clin Neurosci 2009)
    297. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. (PubMed id 18418598)9 LAPb S....Terness P. (Cancer Immunol. Immunother. 2009)
    298. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo. (PubMed id 18397228)9 Iwamoto N....Seishima M. (Liver Int. 2009)
    299. Impaired expression of indoleamine 2, 3-dioxygenase in monocyte-derived dendritic cells in response to Toll-like receptor-7/8 ligands. (PubMed id 17725606)9 Furset G....Sioud M. (Immunology 2008)
    300. Priming of peripheral monocytes with prolactin (PRL) sensitizes IFN-gamma-mediated indoleamine 2,3-dioxygenase (IDO) expression without affecting IFN-gamma signaling. (PubMed id 17942160)9 Kawaguchi R....Ra C. (J. Reprod. Immunol. 2008)
    301. Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges. (PubMed id 18847306)9 Quan J....Friend P.J. (Expert Opin Biol Ther 2008)
    302. Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease. (PubMed id 17430113)9 Penberthy W.T. (Curr. Drug Metab. 2007)
    303. Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation. (PubMed id 17136028)9 Brandacher G....Fuchs D. (Kidney Int. 2007)
    304. [Prolactin (PRL) up-regulates indoleamine 2,3-dioxygenase (IDO) expression in CD14+ cells]. (PubMed id 16394644)9 Kawaguchi R....Tanaka T. (Nihon Rinsho Meneki Gakkai Kaishi 2005)
    305. Cytokine regulation of tryptophan metabolism in the hypothalamic-pituitary-adrenal (HPA) axis: implications for protective and toxic consequences in neuroendocrine regulation. (PubMed id 16075385)9 Tu H....Hughes T.K. (Cell. Mol. Neurobiol. 2005)
    306. [Study of indoleamine 2,3-dioxygenase expression in patients with breast cancer]. (PubMed id 16315864)9 Sakurai K....Negishi N. (amp 2005)
    307. Indoleamine 2,3-dioxygenase (IDO) expression in invasive extravillous trophoblast supports role of the enzyme for materno-fetal tolerance. (PubMed id 15063631)9 HAPnig A....KAommerer U. (J. Reprod. Immunol. 2004)
    308. Role of IDO activation in anti-microbial defense in human native astrocytes. (PubMed id 15206712)9 OberdAPrfer C....DAoubener W. (Adv. Exp. Med. Biol. 2003)
    309. IDO (indolamine 2,3-dioxygenase) expression and function in the CNS. (PubMed id 15206723)9 Kwidzinski E....Bechmann I. (Adv. Exp. Med. Biol. 2003)
    310. Analysis of transcription factors regulating induction of indoleamine 2,3-dioxygenase by IFN-gamma. (PubMed id 10714548)9 Du M.X....Taylor M.W. (amp 2000)
    311. Induction of indolamine 2,3-dioxygenase in primary human macrophages by human immunodeficiency virus type 1 is strain dependent. (PubMed id 10756023)9 Grant R.S....Kapoor V. (J. Virol. 2000)
    312. Identification of the indoleamine 2,3-dioxygenase nucleotide sequence in a rat liver transplant model. (PubMed id 11147699)9 Pan T.L....Goto S. (Transpl. Immunol. 2000)
    313. Interferon gamma induced production of indoleamine 2,3 dioxygenase in cultured human synovial cells. (PubMed id 7523670)9 Malone D.G....Ozaki Y. (J. Rheumatol. 1994)
    314. Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock. (PubMed id 19958238)9 Schefold J.C....Reinke P. (Scand. J. Infect. Dis. 2010)
    315. Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study. (PubMed id 19941414)9 Niinisalo P....LehtimAoki T. (Ann. Med. 2010)
    316. Differential regulation of indoleamine-2,3-dioxygenase (IDO) by HIV type 1 clade B and C Tat protein. (PubMed id 19327051)9 Samikkannu T....Nair M.P. (AIDS Res. Hum. Retroviruses 2009)
    317. Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy. (PubMed id 20025603)9 Liu X....Scherle P.A. (Curr Cancer Drug Targets 2009)
    318. The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase. (PubMed id 19738905)9 SA...Andersen M.H. (PLoS ONE 2009)
    319. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. (PubMed id 18472208)9 Liu H.T....Kuo H.C. (Eur. Urol. 2009)
    320. The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity. (PubMed id 19494274)9 Scott G.N....Mandik-Nayak L. (J. Immunol. 2009)
    321. Skin cells, but not T cells, are resistant to indoleamine 2, 3-dioxygenase (IDO) expressed by allogeneic fibroblasts. (PubMed id 18471256)9 Forouzandeh F....Ghahary A. (Wound Repair Regen 2008)
    322. Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO. (PubMed id 17698915)9 Krause P....Legler D.F. (J. Leukoc. Biol. 2007)
    323. Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO). (PubMed id 17644054)9 Macchiarulo A....Pellicciari R. (Biochim. Biophys. Acta 2007)
    324. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. (PubMed id 16522817)9 von Bergwelt-Baildon M.S....Schultze J.L. (Blood 2006)
    325. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer. (PubMed id 17117179)9 Ino K....Kikkawa F. (Br. J. Cancer 2006)
    326. Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells. (PubMed id 16368976)9 Roshick C....McClarty G. (Infect. Immun. 2006)
    327. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. (PubMed id 15466932)9 Boasso A....Shearer G.M. (Blood 2005)
    328. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. (PubMed id 15390107)9 Guillemin G.J....Brew B.J. (Glia 2005)
    329. CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. (PubMed id 12959949)9 Swanson K.A....Wilkes D.S. (Am. J. Respir. Cell Mol. Biol. 2004)
    330. Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. (PubMed id 15248850)9 von Bubnoff D....Bieber T. (Clin. Exp. Allergy 2004)
    331. Brain virus burden and indoleamine-2,3-dioxygenase expression during lentiviral infection of rhesus monkey are concomitantly lowered by 6-chloro-2',3'-dideoxyguanosine. (PubMed id 15182307)9 Depboylu C....Weihe E. (Eur. J. Neurosci. 2004)
    332. Human primary CD4 + T cells activated in the presence of IFN-alpha 2b express functional indoleamine 2,3-dioxygenase. (PubMed id 11440641)9 Curreli S....Zella D. (amp 2001)
    333. Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells. (PubMed id 10843733)9 Babcock T.A. and Carlin J.M. (Cytokine 2000)
    334. Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha. (PubMed id 8617321)9 DAoubener W....Hadding U. (Eur. J. Immunol. 1996)
    335. Upregulation of interferon-induced indoleamine 2,3-dioxygenase in human macrophage cultures by lipopolysaccharide, muramyl tripeptide, and interleukin-1. (PubMed id 7720088)9 Hissong B.D....Carlin J.M. (Cell. Immunol. 1995)
    336. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. (PubMed id 20368733)9 Shi Y....Ren G. (Cell Res. 2010)
    337. Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. (PubMed id 19625705)9 JA1rgens B....Heitger A. (Blood 2009)
    338. Restriction of Chlamydia pneumoniae replication in human dendritic cell by activation of indoleamine 2,3-dioxygenase. (PubMed id 19643200)9 Njau F....Wagner A.D. (Microbes Infect. 2009)
    339. Targeting of interleukin-10 is superior to cytotoxic T-lymphocyte associated antigen 4 with human immunoglobulin G(1) for the prevention of chronic allograft deterioration in organ transplantation. (PubMed id 18816483)9 Xu T....Tsui T.Y. (J Gene Med 2008)
    340. HCV patients, psychopathology and tryptophan metabolism: analysis of the effects of pegylated interferon plus ribavirin treatment. (PubMed id 17936210)9 Zignego A.L....Moroni F. (Dig Liver Dis 2007)
    341. Upregulation of IFN-gamma receptor expression by proinflammatory cytokines influences IDO activation in epithelial cells. (PubMed id 16426148)9 Shirey K.A....Carlin J.M. (amp 2006)
    342. Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes. (PubMed id 15671534)9 Lee J.H....Essner R. (Clin. Cancer Res. 2005)
    343. Marrying immunotherapy with chemotherapy: why say IDO? (PubMed id 16166276)9 Muller A.J. and Prendergast G.C. (Cancer Res. 2005)
    344. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. (PubMed id 15494706)9 Wichers M.C....Maes M. (Mol. Psychiatry 2005)
    345. Quantification of indoleamine 2,3-dioxygenase gene induction in atopic and non-atopic monocytes after ligation of the high-affinity receptor for IgE, Fc(epsilon)RI and interferon-gamma stimulation. (PubMed id 12699412)9 von Bubnoff D....Bieber T. (Clin. Exp. Immunol. 2003)
    346. Induction of indoleamine 2,3-dioxygenase in primary human macrophages by HIV-1. (PubMed id 10939284)9 Grant R.S....Kapoor V. (Redox Rep. 2000)
    347. Evidence for IRF-1-dependent gene expression deficiency in interferon unresponsive HepG2 cells. (PubMed id 10446388)9 Tnani M. and Bayard B.A. (Biochim. Biophys. Acta 1999)
    348. Tryptophan metabolism in chronic inflammatory lung disease. (PubMed id 7490512)9 Meyer K.C....Brown R.R. (J. Lab. Clin. Med. 1995)
    349. Regulation of indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-gamma. Upstream control region discriminates between interferon-gamma and interferon-alpha. (PubMed id 2174056)9 Dai W. and Gupta S.L. (J. Biol. Chem. 1990)
    350. IFN-gamma is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection. (PubMed id 2116480)9 Takikawa O....Yoshida R. (J. Immunol. 1990)
    351. Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate. (PubMed id 20160032)9 Muller A.J....Prendergast G.C. (Cancer Res. 2010)
    352. Induction of indoleamine 2, 3-dioxygenase by death receptor activation contributes to apoptosis of melanoma cells via mitochondrial damage-dependent ROS accumulation. (PubMed id 19799997)9 Cetindere T....Hassan M. (Cell. Signal. 2010)
    353. Indoleamine 2,3-dioxygenase, an immunomodulatory protein, is suppressed by (-)-epigallocatechin-3-gallate via blocking of gamma-interferon-induced JAK-PKC-delta-STAT1 signaling in human oral cancer cells. (PubMed id 19928918)9 Cheng C.W....Way T.D. (J. Agric. Food Chem. 2010)
    354. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. (PubMed id 19918244)9 Raison C.L....Miller A.H. (Mol. Psychiatry 2010)
    355. Interferon-gamma-mediated pathways are induced in human CD34(+) haematopoietic stem cells. (PubMed id 19765856)9 Kurz K....Fuchs D. (Immunobiology 2010)
    356. Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes. (PubMed id 19948041)9 Liu P....Du J. (BMC Cancer 2009)
    357. Function of the tryptophan metabolite, L-kynurenine, in human corneal endothelial cells. (PubMed id 19597571)9 Serbecic N....Aboul-Enein F. (Mol. Vis. 2009)
    358. Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy. Laboratory investigation. (PubMed id 19199463)9 Miyazaki T....Tsuchiya M. (J. Neurosurg. 2009)
    359. Dual lentivirus infection potentiates neuroinflammation and neurodegeneration: viral copassage enhances neurovirulence. (PubMed id 19115133)9 Afkhami-Goli A....Power C. (J. Neurovirol. 2009)
    360. Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease. (PubMed id 19540675)9 Swardfager W....LanctA't K.L. (Psychoneuroendocrinology 2009)
    361. IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo. (PubMed id 19218483)9 Kim Y.H....Kwon B.S. (J. Leukoc. Biol. 2009)
    362. Is indoleamine 2,3-dioxygenase important for graft acceptance in highly sensitized patients after combined auxiliary liver-kidney transplantation? (PubMed id 19935463)9 Ingelsten M....NystrAPm J. (Transplantation 2009)
    363. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. (PubMed id 19608159)9 Yoo K.H....Koo H.H. (Cell. Immunol. 2009)
    364. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. (PubMed id 19544427)9 Ren G....Shi Y. (Stem Cells 2009)
    365. Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO. (PubMed id 18067553)9 Williams C.A....McLeod J.D. (Immunology 2008)
    366. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. (PubMed id 18465467)9 Miura H....Nagatsu T. (Stress 2008)
    367. Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase. (PubMed id 18665584)9 Kumar S....Muller A.J. (J. Med. Chem. 2008)
    368. Exploring the mechanism of tryptophan 2,3-dioxygenase. (PubMed id 19021508)9 Thackray S.J....Chapman S.K. (Biochem. Soc. Trans. 2008)
    369. [Curcumin inhibiting the expression of indoleamine 2,3-dioxygenase induced by IFN-gamma in cancer cells]. (PubMed id 19112904)9 Zhang K.S....Du J. (Zhong Yao Cai 2008)
    370. Effects of IL-17 on human gingival fibroblasts. (PubMed id 18296612)9 Mahanonda R....Pichyangkul S. (J. Dent. Res. 2008)
    371. Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. (PubMed id 17483297)9 Tas S.W....de Jong E.C. (Blood 2007)
    372. Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses. (PubMed id 17234791)9 Hou D.Y....Munn D.H. (Cancer Res. 2007)
    373. Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression. (PubMed id 17522338)9 Gieseke F....MA1ller I. (Blood 2007)
    374. Comparative effects of two type I interferons, human IFN-alpha and ovine IFN-tau on indoleamine-2,3-dioxygenase in primary cultures of human macrophages. (PubMed id 17227442)9 Maneglier B....Clayette P. (amp 2007)
    375. Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor. (PubMed id 17724200)9 Ryu Y.H. and Kim J.C. (amp 2007)
    376. The etiological role of allogeneic fetal rejection in pre-eclampsia. (PubMed id 17565543)9 Nishizawa H....Udagawa Y. (Am. J. Reprod. Immunol. 2007)
    377. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. (PubMed id 17476344)9 Munn D.H. and Mellor A.L. (J. Clin. Invest. 2007)
    378. IDO expression in the brain: a double-edged sword. (PubMed id 17594069)9 Kwidzinski E. and Bechmann I. (J. Mol. Med. 2007)
    379. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. (PubMed id 17457312)9 MA1ller N. and Schwarz M.J. (Mol. Psychiatry 2007)
    380. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation. (PubMed id 18063923)9 Maes M....Bosmans E. (Neuro Endocrinol. Lett. 2007)
    381. Mechanisms of local immunosuppression in cutaneous melanoma. (PubMed id 17565341)9 Polak M.E....Cree I.A. (Br. J. Cancer 2007)
    382. Intradetrusor injection of botulinum-A toxin in patients with idiopathic and neurogenic detrusor overactivity: urodynamic outcome and patient satisfaction. (PubMed id 17330289)9 Ghalayini I.F. and Al-Ghazo M.A. (Neurourol. Urodyn. 2007)
    383. NF-kappa B activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFN-gamma and tumor necrosis factor-alpha. (PubMed id 16931033)9 Robinson C.M....Carlin J.M. (Cytokine 2006)
    384. Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO. (PubMed id 16888001)9 Basu G.D....Mukherjee P. (J. Immunol. 2006)
    385. The activity of the immunoregulatory enzyme indoleamine 2,3-dioxygenase is decreased in smokers. (PubMed id 16907915)9 Pertovaara M....Hurme M. (Clin. Exp. Immunol. 2006)
    386. Tryptophan degradation increases with stage in patients with rheumatoid arthritis. (PubMed id 16261283)9 Schroecksnadel K....Fuchs D. (Clin. Rheumatol. 2006)
    387. The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines. (PubMed id 16672265)9 Fujigaki H....Seishima M. (J. Biochem. 2006)
    388. The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase. (PubMed id 15684619)9 Robinson C.M....Carlin J.M. (amp 2005)
    389. Association of interferon-gamma +874(T/A) single nucleotide polymorphism with the rate of tryptophan catabolism in healthy individuals. (PubMed id 15853924)9 Raitala A....Hurme M. (Scand. J. Immunol. 2005)
    390. Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus. (PubMed id 16008823)9 Guillemin G.J....Cullen K.M. (Neuropathol. Appl. Neurobiol. 2005)
    391. Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO? (PubMed id 15572592)9 Terness P....Opelz G. (Blood 2005)
    392. The immune environment in human endometrium during the window of implantation. (PubMed id 15494045)9 Lobo S.C....Giudice L.C. (Am. J. Reprod. Immunol. 2004)
    393. Macrophages of human first trimester decidua express markers associated to alternative activation. (PubMed id 14748837)9 Cupurdija K....Sedlmayr P. (Am. J. Reprod. Immunol. 2004)
    394. Double mechanism for apical tryptophan depletion in polarized human bronchial epithelium. (PubMed id 15210815)9 Zegarra-Moran O....Galietta L.J. (J. Immunol. 2004)
    395. Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis: a possible role for the immune system and indoleamine 2,3 dioxygenase (IDO) during involution. (PubMed id 15624557)9 Ritter M.R....Friedlander M. (Lymphat Res Biol 2003)
    396. The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. (PubMed id 12401474)9 Lestage J....Dantzer R. (Brain Behav. Immun. 2002)
    397. Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase. (PubMed id 11553600)9 DAoubener W....Schroten H. (Infect. Immun. 2001)
    398. Tryptophan degradation and immune activation in Alzheimer's disease. (PubMed id 10821443)9 Widner B....Fuchs D. (J Neural Transm 2000)
    399. Enhanced tryptophan degradation in systemic lupus erythematosus. (PubMed id 10834318)9 Widner B....Fuchs D. (Immunobiology 2000)
    400. Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity. (PubMed id 11035763)9 Pantoja L.G....Summersgill J.T. (Infect. Immun. 2000)
    401. Cytokine mediated regulation of interferon-gamma-induced IDO activation. (PubMed id 10721097)9 MacKenzie C.R....DAoubener W. (Adv. Exp. Med. Biol. 1999)
    402. IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism. (PubMed id 10721095)9 DAoubener W. and MacKenzie C.R. (Adv. Exp. Med. Biol. 1999)
    403. Inducible anti-parasitic effector mechanisms in human uroepithelial cells: tryptophan degradation vs. NO production. (PubMed id 10206145)9 DAoubener W....MacKenzie C.R. (Med. Microbiol. Immunol. 1999)
    404. Inhibition of indoleamine 2,3-dioxygenase in human macrophages inhibits interferon-gamma-induced bacteriostasis but does not abrogate toxoplasmastasis. (PubMed id 10540337)9 MacKenzie C.R....DAoubener W. (Eur. J. Immunol. 1999)
    405. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. (PubMed id 9466588)9 Sanni L.A....Hunt N.H. (Am. J. Pathol. 1998)
    406. Inhibition of nitric oxide synthase expression and activity in macrophages by 3-hydroxyanthranilic acid, a tryptophan metabolite. (PubMed id 9126284)9 SekkaA^ D....Lepoivre M. (Arch. Biochem. Biophys. 1997)
    407. The role of indoleamine 2,3-dioxygenase in the anti-tumour activity of human interferon-gamma in vivo. (PubMed id 7814143)9 Burke F....Balkwill F.R. (Int. J. Cancer 1995)
    408. Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia. (PubMed id 7617307)9 Sardar A.M. and Reynolds G.P. (Neurosci. Lett. 1995)
    409. Human indoleamine 2,3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells. (PubMed id 7897249)9 Dai W....Dubey J.P. (J. Interferon Res. 1994)
    410. Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. (PubMed id 8118042)9 Musso T....Varesio L. (Blood 1994)
    411. Differential regulation of human indoleamine 2,3-dioxygenase gene expression by interferons-gamma and -alpha. Analysis of the regulatory region of the gene and identification of an interferon-gamma-inducible DNA-binding factor. (PubMed id 8444884)9 Hassanain H.H....Gupta S.L. (J. Biol. Chem. 1993)
    412. Reversal of an interferon-gamma-resistant phenotype by poly(I:C): possible role of double-stranded RNA-activated kinase in interferon-gamma signaling. (PubMed id 7901291)9 Ozes O.N. and Taylor M.W. (J. Interferon Res. 1993)
    413. Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS. (PubMed id 1722946)9 Brown R.R....Malone D.G. (Adv. Exp. Med. Biol. 1991)
    414. Analysis of interferon-gamma resistant mutants that are possibly defective in their signaling mechanism. (PubMed id 1720865)9 Feng G.S....Taylor M.W. (amp 1991)
    415. Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle. (PubMed id 2395002)9 Schiller J.H....Borden E.C. (J Biol Response Mod 1990)
    416. Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis. (PubMed id 20437560)9 Correale J. and Villa A. (Ann. Neurol. 2010)
    417. Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors. (PubMed id 20124451)9 Koblish H.K....Fridman J.S. (Mol. Cancer Ther. 2010)
    418. Rational design of indoleamine 2,3-dioxygenase inhibitors. (PubMed id 20055453)9 RAPhrig U.F....Michielin O. (J. Med. Chem. 2010)
    419. Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds. (PubMed id 20100004)9 Di Pucchio T....Rutella S. (Expert Opin Ther Pat 2010)
    420. Human chorionic gonadotropin: a hormone with immunological and angiogenic properties. (PubMed id 20227765)9 Tsampalas M....Perrier d'Hauterive S. (J. Reprod. Immunol. 2010)
    421. The kynurenine pathway and inflammation in amyotrophic lateral sclerosis. (PubMed id 19921535)9 Chen Y....Guillemin G.J. (Neurotox Res 2010)
    422. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues. (PubMed id 20000778)9 Terentis A.C....Thomas S.R. (Biochemistry 2010)
    423. Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis. (PubMed id 20181893)9 Ciorba M.A....Stenson W.F. (J. Immunol. 2010)
    424. The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study. (PubMed id 19778568)9 Gabbay V....Gonen O. (amp 2010)
    425. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. (PubMed id 20067407)9 Hemeda H....Brandau S. (Stem Cells Dev. 2010)
    426. Effect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice. (PubMed id 20356392)9 Moheno P....Fuchs D. (J Transl Med 2010)
    427. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. (PubMed id 20126406)9 Prasanna S.J....Vasandan A.B. (PLoS ONE 2010)
    428. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity. (PubMed id 20197554)9 Liu X....Scherle P.A. (Blood 2010)
    429. COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence. (PubMed id 20047157)9 MA1ller N. (Curr Opin Investig Drugs 2010)
    430. Transfection of indoleamine 2,3 dioxygenase in primary endothelial cells. (PubMed id 20379874)9 Mouratidis P.X. and George A.J. (Methods Mol. Biol. 2010)
    431. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. (PubMed id 20207200)9 Chen K....Han Z.C. (Clin. Immunol. 2010)
    432. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. (PubMed id 19923445)9 Zhang Q....Le A.D. (J. Immunol. 2009)
    433. Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockade. (PubMed id 19118070)9 Ribas A....Cochran A.J. (Clin. Cancer Res. 2009)
    434. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors. (PubMed id 18986303)9 Ploder M....Fuchs D. (Clin. Sci. 2009)
    435. Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism. (PubMed id 19740324)9 Joo Y.D....Seo S.K. (Immunology 2009)
    436. Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. (PubMed id 19307751)9 Yang S.H....Park C.G. (amp 2009)
    437. An anti-inflammatory role for plasmacytoid dendritic cells in allergic airway inflammation. (PubMed id 19553531)9 Kool M....Hammad H. (J. Immunol. 2009)
    438. Low levels of serum asymmetric antibodies as a marker of threatened pregnancy. (PubMed id 19233480)9 Barrientos G....Blois S.M. (J. Reprod. Immunol. 2009)
    439. Modulation of indoleamine-2,3-dioxygenase expression and activity by HIV-1 in human macrophages. (PubMed id 19656212)9 ManAcglier B....Clayette P. (amp 2009)
    440. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. (PubMed id 19231921)9 DelaRosa O....BA1scher D. (Tissue Eng Part A 2009)
    441. Binding immunoglobulin protein-treated peripheral blood monocyte-derived dendritic cells are refractory to maturation and induce regulatory T-cell development. (PubMed id 19740378)9 Corrigall V.M....Panayi G.S. (Immunology 2009)
    442. Nicotinic acid-mediated activation of both membrane and nuclear receptors towards therapeutic glucocorticoid mimetics for treating multiple sclerosis. (PubMed id 19461950)9 Penberthy W.T. (PPAR Res 2009)
    443. Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer. (PubMed id 19491279)9 Qian F....Odunsi K. (Cancer Res. 2009)
    444. [Indoleamine 2,3-dioxygenase activity during chemotherapy in patients with breast cancer]. (PubMed id 20037301)9 Sakurai K....Amano S. (amp 2009)
    445. IDO and outcomes in ovarian cancer. (PubMed id 19822256)9 Nelson B.H. (Gynecol. Oncol. 2009)
    446. Kynurenine pathway in psychosis: evidence of increased tryptophan degradation. (PubMed id 18562404)9 Barry S....Dinan T.G. (J. Psychopharmacol. (Oxford) 2009)
    447. Immunomodulatory effects of Turkish propolis: changes in neopterin release and tryptophan degradation. (PubMed id 19167991)9 Girgin G....Fuchs D. (Immunobiology 2009)
    448. TGF-beta and kynurenines as the key to infectious tolerance. (PubMed id 19162548)9 Belladonna M.L....Puccetti P. (Trends Mol Med 2009)
    449. Targeting indoleamine 2,3-dioxygenase (IDO) to counteract tumour-induced immune dysfunction: from biochemistry to clinical development. (PubMed id 19519465)9 Rutella S....De Cristofaro R. (amp 2009)
    450. Interaction of indoleamine-2,3-dioxyagnase and CD4+CD25+ regulatory T cells in tumor immune escape. (PubMed id 19550135)9 Wang H....Xia J.C. (Ai Zheng 2009)
    451. Indoleamine 2,3-dioxygenase in tumor induced tolerance. (PubMed id 20137504)9 Liu X.Q. and Wang X. (Chin. Med. J. 2009)
    452. Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma. (PubMed id 19665763)9 Inaba T....Kikkawa F. (Gynecol. Oncol. 2009)
    453. Interferon-gamma-mediated pathways and in vitro PBMC proliferation in HIV-infected patients. (PubMed id 19040353)9 Schroecksnadel K....Zangerle R. (Biol. Chem. 2009)
    454. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients]. (PubMed id 19853722)9 Vignau J....Lhermitte M. (Encephale 2009)
    455. Neuropsychiatric disorders related to interferon and interleukins treatment. (PubMed id 19067144)9 Myint A.M....Leonard B.E. (Metab Brain Dis 2009)
    456. Antimicrobial and immunoregulatory effector mechanisms in human endothelial cells. Indoleamine 2,3-dioxygenase versus inducible nitric oxide synthase. (PubMed id 19967141)9 DAoubener W....MacKenzie C.R. (Thromb. Haemost. 2009)
    457. Immunomodulatory properties of human periodontal ligament stem cells. (PubMed id 19160415)9 Wada N....Gronthos S. (J. Cell. Physiol. 2009)
    458. Reassessment of the reaction mechanism in the heme dioxygenases. (PubMed id 19275153)9 Chauhan N....Raven E.L. (J. Am. Chem. Soc. 2009)
    459. Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. (PubMed id 19143868)9 Nasef A....Chapel A. (Int J Lab Hematol 2009)
    460. Nociceptin-induced modulation of human T cell function. (PubMed id 19428771)9 Easten K.H....McLeod J.D. (Peptides 2009)
    461. The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology. (PubMed id 19023117)9 Curti A....Lemoli R.M. (Blood 2009)
    462. Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. (PubMed id 19421183)9 Bonifazi P....Romani L. (Mucosal Immunol 2009)
    463. Indoleamine 2,3-dioxygenase overexpression causes kynurenine-modification of proteins, fiber cell apoptosis and cataract formation in the mouse lens. (PubMed id 19308046)9 Mailankot M....Nagaraj R.H. ( a journal of technical methods and pathology 2009)
    464. Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? (PubMed id 19461669)9 LAPb S....Terness P. (Nat. Rev. Cancer 2009)
    465. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease. (PubMed id 18612775)9 Macchiarulo A....Pellicciari R. (Amino Acids 2009)
    466. Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. (PubMed id 19535630)9 Almeida A.S....Ho J.L. (J. Immunol. 2009)
    467. Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases. (PubMed id 19534572)9 Tan P.H. and Bharath A.K. (Expert Opin. Ther. Targets 2009)
    468. Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host. (PubMed id 19007906)9 Zelante T....Romani L. (Microbes Infect. 2009)
    469. Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity. (PubMed id 18639341)9 Hoshi M....Seishima M. (Leuk. Res. 2009)
    470. IDO recruits Tregs in melanoma. (PubMed id 19471123)9 Prendergast G.C....Muller A.J. (Cell Cycle 2009)
    471. Mouse model for allogeneic immune reaction against fetus recapitulates human pre-eclampsia. (PubMed id 18226121)9 Nishizawa H....Udagawa Y. (J. Obstet. Gynaecol. Res. 2008)
    472. Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status. (PubMed id 18950381)9 Van Gool A.R....Hengeveld M.W. (Psychiatry Clin. Neurosci. 2008)
    473. Density functional theory study on a missing piece in understanding of heme chemistry: the reaction mechanism for indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase. (PubMed id 18712870)9 Chung L.W....Morokuma K. (J. Am. Chem. Soc. 2008)
    474. MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma. (PubMed id 18713982)9 Tinder T.L....Mukherjee P. (J. Immunol. 2008)
    475. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity. (PubMed id 18823288)9 Fitzgerald P....Dinan Timothy G. (Neurogastroenterol. Motil. 2008)
    476. HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation. (PubMed id 18698365)9 Boasso A....Shearer G.M. (PLoS ONE 2008)
    477. The characterization and role of regulatory T cells in immune reactions. (PubMed id 17981708)9 Wilczynski J.R....Kalinka J. (Front. Biosci. 2008)
    478. IDO: a double-edged sword for T(H)1/T(H)2 regulation. (PubMed id 18824197)9 Xu H....Rostami A. (Immunol. Lett. 2008)
    479. IFN-gamma mediated pathways in patients with fatigue and chronic active Epstein Barr virus-infection. (PubMed id 17945348)9 Bellmann-Weiler R....Weiss G. (J Affect Disord 2008)
    480. COX-2 inhibition in schizophrenia and major depression. (PubMed id 18537668)9 MA1ller N. and Schwarz M.J. (Curr. Pharm. Des. 2008)
    481. Alpha-galactosylceramide modulates the induction of indoleamine 2,3-dioxygenase in antigen presenting cells. (PubMed id 18671950)9 Fallarini S....Lombardi G. (Biochem. Pharmacol. 2008)
    482. A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders. (PubMed id 18516521)9 MA1ller N. and Schwarz M.J. (Eur Arch Psychiatry Clin Neurosci 2008)
    483. Evidence that the bulge region is a site of relative immune privilege in human hair follicles. (PubMed id 18795933)9 Meyer K.C....Paus R. (Br. J. Dermatol. 2008)
    484. Cell cycle arrest by kynurenine in lens epithelial cells. (PubMed id 18676626)9 Mailankot M....Nagaraj R.H. (amp 2008)
    485. Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival. (PubMed id 18413819)9 Ino K....Kikkawa F. (Clin. Cancer Res. 2008)
    486. Effect of 3-hydroxyanthranilic acid in the immunosuppressive molecules indoleamine dioxygenase and HLA-G in macrophages. (PubMed id 18289708)9 LA^pez A.S....GonzA!lez A. (Immunol. Lett. 2008)
    487. Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction. (PubMed id 17945538)9 Davis P.M....Suchard S.J. (Clin. Immunol. 2008)
    488. Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation. (PubMed id 18367721)9 Emmons J....Brooks S.A. (RNA 2008)
    489. Adenosine receptors in regulation of dendritic cell differentiation and function. (PubMed id 18559975)9 Novitskiy S.V....Dikov M.M. (Blood 2008)
    490. IDO-expressing regulatory dendritic cells in cancer and chronic infection. (PubMed id 17876564)9 Popov A. and Schultze J.L. (J. Mol. Med. 2008)
    491. Emerging concepts in CD8(+) T regulatory cells. (PubMed id 18406591)9 Niederkorn J.Y. (Curr. Opin. Immunol. 2008)
    492. Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach. (PubMed id 18429497)9 GonzA!lez A....Melero I. (Adv Clin Chem 2008)
    493. Fetal tolerance in human pregnancy--a crucial balance between acceptance and limitation of trophoblast invasion. (PubMed id 18055021)9 von Rango U. (Immunol. Lett. 2008)
    494. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity. (PubMed id 18343564)9 Apostolidis A....Fowler C.J. (Eur. Urol. 2008)
    495. [Potential endogenous immunological self-protection of uveal melanoma by indoleamine 2,3-dioxygenase]. (PubMed id 18712654)9 Beutelspacher S.C. and Serbecic N. (Klin Monbl Augenheilkd 2008)
    496. Tumor-educated tolerogenic dendritic cells induce CD3epsilon down-regulation and apoptosis of T cells through oxygen-dependent pathways. (PubMed id 18713979)9 Kuang D.M....Zheng L. (J. Immunol. 2008)
    497. Histidine 55 of tryptophan 2,3-dioxygenase is not an active site base but regulates catalysis by controlling substrate binding. (PubMed id 18783250)9 Thackray S.J....Chapman S.K. (Biochemistry 2008)
    498. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism. (PubMed id 17881253)9 Puccetti P. and Fallarino F. (amp 2008)
    499. High expression of indoleamine 2,3-dioxygenase gene in prostate cancer. (PubMed id 18619832)9 Feder-Mengus C....Provenzano M. (Eur. J. Cancer 2008)
    500. Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction? (PubMed id 18064486)9 LAPb S. and KAPnigsrainer A. (Langenbecks Arch Surg 2008)
    501. Evolving immunosuppressive microenvironment during human cervical carcinogenesis. (PubMed id 19079205)9 Kobayashi A....Smith-McCune K. (Mucosal Immunol 2008)
    502. Indoleamine 2,3-dioxygenase in materno-fetal interaction. (PubMed id 17430108)9 Sedlmayr P. (Curr. Drug Metab. 2007)
    503. Indoleamine 2,3-dioxygenase in hematopoietic stem cell transplantation. (PubMed id 17430114)9 Hainz U....Heitger A. (Curr. Drug Metab. 2007)
    504. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. (PubMed id 17767193)9 Puccetti P. and Grohmann U. (Nat. Rev. Immunol. 2007)
    505. The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. (PubMed id 17982903)9 MiA1ller N. and Schwarz M.J. (J. Neural Transm. Suppl. 2007)
    506. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virus-infected subjects with no lymphadenopathy: the parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches. (PubMed id 17303977)9 Prandota J. (Am J Ther 2007)
    507. The pro- and anti-inflammatory properties of human antigen-presenting cells expressing the high affinity receptor for IgE (Fc epsilon RI). (PubMed id 17544834)9 Bieber T. (Immunobiology 2007)
    508. Indoleamine-2, 3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection. (PubMed id 17430111)9 Schroecksnadel K....Fuchs D. (Curr. Drug Metab. 2007)
    509. The second enzyme in pyrrolnitrin biosynthetic pathway is related to the heme-dependent dioxygenase superfamily. (PubMed id 17924666)9 De Laurentis W....Naismith J.H. (Biochemistry 2007)
    510. IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells. (PubMed id 17948274)9 Hill M....Anegon I. (Eur. J. Immunol. 2007)
    511. The immunoregulatory function of indoleamine 2, 3 dioxygenase and its application in allotransplantation. (PubMed id 18094439)9 Jalili R.B....Ghahary A. (Iran J Allergy Asthma Immunol 2007)
    512. Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season. (PubMed id 17711489)9 Pertovaara M....Hurme M. (Clin. Exp. Immunol. 2007)
    513. [Immunology in schizophrenic disorders]. (PubMed id 16897051)9 MA1ller N. and Schwarz M.J. (Nervenarzt 2007)
    514. IDO and clinical conditions associated with depressive symptoms. (PubMed id 17430116)9 Kohl C. and Sperner-Unterweger B. (Curr. Drug Metab. 2007)
    515. CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model. (PubMed id 17513732)9 Elpek K.G....Shirwan H. (J. Immunol. 2007)
    516. Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle. (PubMed id 17896864)9 Kaper T....Frommer W.B. (PLoS Biol. 2007)
    517. Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients. (PubMed id 17191041)9 Weinlich G....Fuchs D. (Dermatology (Basel) 2007)
    518. Differentiation potential of urothelium from patients with benign bladder dysfunction. (PubMed id 17537219)9 Southgate J....Eardley I. (BJU Int. 2007)
    519. Molecules in focus: indoleamine 2,3-dioxygenase. (PubMed id 17320464)9 King N.J. and Thomas S.R. (amp 2007)
    520. Tryptophan metabolism and indoleamine 2,3-dioxygenase expression in coeliac disease. (PubMed id 17362267)9 Torres M.I....RA-os A. (Clin. Exp. Immunol. 2007)
    521. Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection. (PubMed id 17715231)9 Boasso A....Chougnet C. (J. Virol. 2007)
    522. Chronic immune activation underlies morbid obesity: is IDO a key player? (PubMed id 17430117)9 Brandacher G....Weiss H.G. (Curr. Drug Metab. 2007)
    523. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. (PubMed id 17521318)9 Ryan J.M....Mahon B.P. (Clin. Exp. Immunol. 2007)
    524. Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. (PubMed id 17605296)9 Nasef A....Fouillard L. (Gene Expr. 2007)
    525. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. (PubMed id 17164341)9 Curti A....Lemoli R.M. (Blood 2007)
    526. The role of indoleamine 2,3-dioxygenase in transplantation. (PubMed id 17239019)9 Hainz U....Heitger A. (Transpl. Int. 2007)
    527. Decreased protein nitration in macrophages that overexpress indoleamine 2, 3-dioxygenase. (PubMed id 17103092)9 Keskin D.B....Gearhart D.A. (amp 2007)
    528. Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study. (PubMed id 17349013)9 Pertovaara M....Hurme M. (Clin. Exp. Immunol. 2007)
    529. Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression. (PubMed id 17195079)9 Wobser M....Becker J.C. (Cancer Immunol. Immunother. 2007)
    530. Tumor immune escape mediated by indoleamine 2,3-dioxygenase. (PubMed id 17644189)9 Zamanakou M....Karanikas V. (Immunol. Lett. 2007)
    531. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses. (PubMed id 17881247)9 Rouas-Freiss N....Carosella E.D. (Semin. Cancer Biol. 2007)
    532. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes. (PubMed id 17360980)9 Ueno A....Yang Y. (Diabetes 2007)
    533. How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation. (PubMed id 17430110)9 Boasso A. and Shearer G.M. (Curr. Drug Metab. 2007)
    534. Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. (PubMed id 17430112)9 MacKenzie C.R....DAoubener W. (Curr. Drug Metab. 2007)
    535. Functional role of P-selectin glycoprotein ligand 1/P-selectin interaction in the generation of tolerogenic dendritic cells. (PubMed id 18025190)9 Urzainqui A....SA!nchez-Madrid F. (J. Immunol. 2007)
    536. CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. (PubMed id 16896154)9 Hryniewicz A....Franchini G. (Blood 2006)
    537. Calcium-pterin suppresses mitogen-induced tryptophan degradation and neopterin production in peripheral blood mononuclear cells. (PubMed id 17113915)9 Winkler C....Fuchs D. (Immunobiology 2006)
    538. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells. (PubMed id 16490253)9 LA^pez A.S....GonzA!lez A. (Mol. Immunol. 2006)
    539. Immune mechanisms of allergen-specific sublingual immunotherapy. (PubMed id 16409190)9 Moingeon P....Van Overtvelt L. (Allergy 2006)
    540. Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients. (PubMed id 16687019)9 Brandacher G....Weiss H.G. (Obes Surg 2006)
    541. Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection? (PubMed id 16881731)9 Faal N....Holland M.J. (PLoS Med. 2006)
    542. Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia - the same basic mechanism? (PubMed id 16829304)9 WilczyA8ski J.R. (Hum. Immunol. 2006)
    543. Monitoring tryptophan metabolism in chronic immune activation. (PubMed id 16139256)9 SchrAPcksnadel K....Fuchs D. ( international journal of clinical chemistry 2006)
    544. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. (PubMed id 17062375)9 Muller N. and Schwarz M. (Neurotox Res 2006)
    545. 4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms. (PubMed id 16899371)9 Choi B.K....Kwon B.S. (Cytokine 2006)
    546. Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors. (PubMed id 16420054)9 Gaspari P....Donovan A.M. (J. Med. Chem. 2006)
    547. Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo. (PubMed id 16527542)9 Wood K.J. and Sawitzki B. (Trends Immunol. 2006)
    548. Regulatory T cell maintenance of dominant tolerance: induction of tissue self-defense? (PubMed id 17157205)9 Oliveira V....Graca L. (Transpl. Immunol. 2006)
    549. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. (PubMed id 16902147)9 Nilsson J....Chougnet C. (Blood 2006)
    550. Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute. (PubMed id 16417228)9 Li Y....Ghahary A. (J. Invest. Dermatol. 2006)
    551. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. (PubMed id 16957024)9 Evans K.N....Hewison M. (Biol. Reprod. 2006)
    552. TNF regulates cellular NAD+ metabolism in primary macrophages. (PubMed id 16516847)9 Iqbal J. and Zaidi M. (Biochem. Biophys. Res. Commun. 2006)
    553. Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition. (PubMed id 17114500)9 Zhu L....Zhang Y. (J. Immunol. 2006)
    554. Pain during ice water test distinguishes clinical bladder hypersensitivity from overactivity disorders. (PubMed id 17192176)9 Mukerji G....Anand P. (BMC Urol 2006)
    555. Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation. (PubMed id 16460921)9 Munn D.H. (Curr. Opin. Immunol. 2006)
    556. Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. (PubMed id 17111046)9 Popov A....Schultze J.L. (J. Clin. Invest. 2006)
    557. Inhibitors of human indoleamine 2,3-dioxygenase identified with a target-based screen in yeast. (PubMed id 16897708)9 Vottero E....Roberge M. (Biotechnol J 2006)
    558. Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines. (PubMed id 16385630)9 Weber W.P....Spagnoli G.C. (Eur. J. Immunol. 2006)
    559. Proteolytic processing of SDF-1alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration. (PubMed id 17148615)9 Vergote D....Power C. (Proc. Natl. Acad. Sci. U.S.A. 2006)
    560. Cytochrome b(5) is a major reductant in vivo of human indoleamine 2,3-dioxygenase expressed in yeast. (PubMed id 16574111)9 Vottero E....Mauk A.G. (FEBS Lett. 2006)
    561. The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. (PubMed id 16894392)9 Spalletta G....Robinson R.G. (Mol. Psychiatry 2006)
    562. A high-affinity, tryptophan-selective amino acid transport system in human macrophages. (PubMed id 16997853)9 Seymour R.L....Munn D.H. (J. Leukoc. Biol. 2006)
    563. Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. (PubMed id 16741252)9 Romani L....Puccetti P. (Blood 2006)
    564. Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites. (PubMed id 16468035)9 Harlin H....Gajewski T.F. (Cancer Immunol. Immunother. 2006)
    565. Indoleamine-2,3-dioxygenase modulation of allergic immune responses. (PubMed id 16476191)9 Le A.V. and Broide D.H. (Curr Allergy Asthma Rep 2006)
    566. [Indoleamine 2, 3-dioxygenase activity in acute myeloid leukemia cells contributing to tumor immune escape]. (PubMed id 16800938)9 Tang X.Q....Zou P. (Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006)
    567. Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury. (PubMed id 16293800)9 Liu H....Visner G.A. (Am. J. Respir. Crit. Care Med. 2006)
    568. The HPA and immune axes in stress: the involvement of the serotonergic system. (PubMed id 16459240)9 Leonard B.E. (Eur. Psychiatry 2005)
    569. Current concepts of tumor-infiltrating lymphocytes in human malignancies. (PubMed id 16111767)9 Chiou S.H....Hong-Nerng H. (J. Reprod. Immunol. 2005)
    570. Role of human brain microvascular endothelial cells during central nervous system infection. Significance of indoleamine 2,3-dioxygenase in antimicrobial defence and immunoregulation. (PubMed id 16113824)9 Adam R....DAoubener W. (Thromb. Haemost. 2005)
    571. Interferon-beta affects the tryptophan metabolism in multiple sclerosis patients. (PubMed id 16053472)9 Amirkhani A....Bergquist J. (Eur. J. Neurol. 2005)
    572. Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors. (PubMed id 16083346)9 Muller A.J....Prendergast G.C. (Expert Opin. Ther. Targets 2005)
    573. Enhanced enzymatic degradation of tryptophan by indoleamine 2,3-dioxygenase contributes to the tryptophan-deficient state seen after major trauma. (PubMed id 15718917)9 Pellegrin K....Fuchs D. (Shock 2005)
    574. Role of Indoleamine 2,3-Dioxygenase in Antiviral Activity of Interferon-gamma Against Vaccinia Virus. (PubMed id 16359238)9 Terajima M. and Leporati A.M. (Viral Immunol. 2005)
    575. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. (PubMed id 15967784)9 Baban B....Mellor A.L. (Int. Immunol. 2005)
    576. Microparticle-free placentally derived soluble factors downmodulate the response of activated T cells. (PubMed id 16360837)9 Gupta A.K....Hahn S. (Hum. Immunol. 2005)
    577. Enhancement of antimicrobial effects by glucocorticoids. (PubMed id 14624357)9 TA1rck J....DAoubener W. (Med. Microbiol. Immunol. 2005)
    578. Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells. (PubMed id 16118322)9 Marteau F....Communi D. (Blood 2005)
    579. Chronicles in drug discovery. (PubMed id 16034484)9 Khurdayan V. and Cullell-Young M. (amp 2005)
    580. Cytokines and major depression. (PubMed id 15694227)9 Schiepers O.J....Maes M. (amp 2005)
    581. Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden. (PubMed id 15732262)9 Huang Y.M....Link H. (Mult. Scler. 2005)
    582. [Metabolism of tryptophan via the kynurenine pathway in saliva]. (PubMed id 15995595)9 Buczko W....Stokowska W. (Postepy Hig Med Dosw (Online) 2005)
    583. The effect of fluid intake on urinary symptoms in women. (PubMed id 15947624)9 Swithinbank L....Abrams P. (J. Urol. 2005)
    584. Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines. (PubMed id 15780178)9 Hwang S.L....Lin C.L. (Cell Res. 2005)
    585. Lack of microbicidal response in human macrophages infected with Parachlamydia acanthamoebae. (PubMed id 15826869)9 Greub G....Mege J.L. (Microbes Infect. 2005)
    586. Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. (PubMed id 15961516)9 Potula R....Persidsky Y. (Blood 2005)
    587. Tryptophan degradation in patients with gynecological cancer correlates with immune activation. (PubMed id 15896467)9 Schroecksnadel K....Fuchs D. (Cancer Lett. 2005)
    588. Gene combination transfer to block autoimmune damage in transplanted islets of Langerhans. (PubMed id 15512788)9 Bertera S....Trucco M. (Exp. Diabesity Res. 2004)
    589. Expression of indoleamine 2,3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor. (PubMed id 15102086)9 Ghahary A....Lin X. (J. Invest. Dermatol. 2004)
    590. Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. (PubMed id 14963171)9 Adams O....DAoubener W. (J. Virol. 2004)
    591. Optimised expression and purification of recombinant human indoleamine 2,3-dioxygenase. (PubMed id 15358362)9 Austin C.J....Jamie J.F. (Protein Expr. Purif. 2004)
    592. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. (PubMed id 14719046)9 Wichers M.C. and Maes M. (amp 2004)
    593. Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. (PubMed id 15380529)9 Wolf A.M....Tilg H. (Clin. Immunol. 2004)
    594. Phenotypic characterization of regulatory T cells in the human decidua. (PubMed id 15086404)9 Heikkinen J....Lassila O. (Clin. Exp. Immunol. 2004)
    595. Drug abuse and neuropathogenesis of HIV infection: role of DC-SIGN and IDO. (PubMed id 15579280)9 Nair M.P....Hewitt R. (J. Neuroimmunol. 2004)
    596. Gene expression of enzymes for tryptophan degradation pathway is upregulated in the skin lesions of patients with atopic dermatitis or psoriasis. (PubMed id 15541637)9 Ito M....Ra C. (J. Dermatol. Sci. 2004)
    597. Tryptophan metabolism along the kynurenine pathway in diet-induced and genetic hypercholesterolemic rabbits. (PubMed id 15530458)9 Allegri G....Bertazzo A. ( international journal of clinical chemistry 2004)
    598. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. (PubMed id 15302611)9 Frick B....Fuchs D. (Clin. Biochem. 2004)
    599. IDO and tolerance to tumors. (PubMed id 14720581)9 Munn D.H. and Mellor A.L. (Trends Mol Med 2004)
    600. Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. (PubMed id 15056470)9 Miller C.L....Weis S. (Neurobiol. Dis. 2004)
    601. Predominant contribution of IFN-beta expression to apoptosis induction in human uterine cervical fibroblast cells by influenza-virus infection. (PubMed id 15516717)9 Ohyama K....Toyoda H. (amp 2004)
    602. Determination of the nature of the heme environment in nitrosyl indoleamine 2,3-dioxygenase using Multiple-scattering analyses of X-ray absorption fine structure. (PubMed id 15109246)9 Aitken J.B....Lay P.A. (Biochemistry 2004)
    603. Down-regulatory effect of N-chlorotaurine on tryptophan degradation and neopterin production in human PBMC. (PubMed id 15158610)9 Wirleitner B....Fuchs D. (Immunol. Lett. 2004)
    604. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. (PubMed id 15254594)9 Hayashi T....Raz E. (J. Clin. Invest. 2004)
    605. Tryptophan degradation during and after gestation. (PubMed id 15206718)9 SchrAPcksnadel K....Fuchs D. (Adv. Exp. Med. Biol. 2003)
    606. Increased mRNA expression of kynurenine pathway enzymes in human placentae exposed to bacterial endotoxin. (PubMed id 15206719)9 Manuelpillai U....Walker D. (Adv. Exp. Med. Biol. 2003)
    607. Longitudinal study of tryptophan degradation during and after pregnancy. (PubMed id 12479977)9 SchrAPcksnadel K....Fuchs D. (Life Sci. 2003)
    608. Expression of indoleamine 2,3-dioxygenase in carcinoma of human endometrium and uterine cervix. (PubMed id 15206720)9 Sedlmayr P....Dohr G. (Adv. Exp. Med. Biol. 2003)
    609. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. (PubMed id 14592780)9 Myint A.M. and Kim Y.K. (Med. Hypotheses 2003)
    610. Tryptophan catabolism and T cell responses. (PubMed id 15206713)9 Mellor A.L....Baban B. (Adv. Exp. Med. Biol. 2003)
    611. Phenotypic characterization of human decidual macrophages. (PubMed id 12605704)9 Heikkinen J....Lassila O. (Clin. Exp. Immunol. 2003)
    612. Quinolinic acid in the pathogenesis of Alzheimer's disease. (PubMed id 15206729)9 Guillemin G.J....Brew B.J. (Adv. Exp. Med. Biol. 2003)
    613. Comparison of the sequences of Turbo and Sulculus indoleamine dioxygenase-like myoglobin genes. (PubMed id 12711393)9 Suzuki T....Yuasa H.J. (Gene 2003)
    614. Increased degradation of tryptophan in blood of patients with rheumatoid arthritis. (PubMed id 12966593)9 Schroecksnadel K....Fuchs D. (J. Rheumatol. 2003)
    615. At the innate frontiers between mother and fetus: linking abortion with complement activation. (PubMed id 12594944)9 Caucheteux S.M....Ojcius D.M. (Immunity 2003)
    616. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. (PubMed id 15206745)9 Neurauter G....Fuchs D. (Adv. Exp. Med. Biol. 2003)
    617. Tryptophan as a link between psychopathology and somatic states. (PubMed id 12883120)9 Russo S....Korf J. (Psychosom Med 2003)
    618. Comparative effects of L-tryptophan and 1-methyl-tryptophan on immunoregulation induced by sperm, human pre-implantation embryo and trophoblast supernatants. (PubMed id 14672333)9 GutiAcrrez G....Markert U.R. (Am. J. Reprod. Immunol. 2003)
    619. Age-related nuclear cataract and indoleamine 2,3-dioxygenase-initiated tryptophan metabolism in the human lens. (PubMed id 15206741)9 Takikawa O....Miwa S. (Adv. Exp. Med. Biol. 2003)
    620. [A new mechanism of tumor resistance to the immune system, based on tryptophan breakdown by indoleamine 2,3-dioxygenase]. (PubMed id 15132006)9 Van den Eynde B. (Bull. Mem. Acad. R. Med. Belg. 2003)
    621. Expression of the kynurenine pathway enzymes in human microglia and macrophages. (PubMed id 15206722)9 Guillemin G.J....Brew B.J. (Adv. Exp. Med. Biol. 2003)
    622. Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma. (PubMed id 14563947)9 Lee J.R....Munn D.H. ( a journal of technical methods and pathology 2003)
    623. Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. (PubMed id 12871129)9 Wirleitner B....Fuchs D. (Curr. Med. Chem. 2003)
    624. A beta 1-42 induces production of quinolinic acid by human macrophages and microglia. (PubMed id 14663182)9 Guillemin G.J....Brew B.J. (Neuroreport 2003)
    625. Proliferation of peripheral blood mononuclear cells is suppressed by the indoleamine 2,3-dioxygenase expression of interferon-gamma-treated skin cells in a co-culture system. (PubMed id 12950637)9 Sarkhosh K....Ghahary A. (Wound Repair Regen 2003)
    626. FcepsilonRI induces the tryptophan degradation pathway involved in regulating T cell responses. (PubMed id 12165503)9 von Bubnoff D....Bieber T. (J. Immunol. 2002)
    627. Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains. (PubMed id 12414962)9 Burudi E.M....Fox H.S. (J. Virol. 2002)
    628. Lens epithelial cell apoptosis and intracellular Ca2+ increase in the presence of xanthurenic acid. (PubMed id 11934353)9 Malina H....Hess O.M. (BMC Ophthalmol 2002)
    629. HeLa cells cocultured with peripheral blood lymphocytes acquire an immuno-inhibitory phenotype through up-regulation of indoleamine 2,3-dioxygenase activity. (PubMed id 11985668)9 Logan G.J....Alexander I.E. (Immunology 2002)
    630. Potential role of human brain microvascular endothelial cells in the pathogenesis of brain abscess: inhibition of Staphylococcus aureus by activation of indoleamine 2,3-dioxygenase. (PubMed id 11571701)9 Schroten H....DAoubener W. (Neuropediatrics 2001)
    631. 3-Hydroxyanthranilic acid, an L-tryptophan metabolite, induces apoptosis in monocyte-derived cells stimulated by interferon-gamma. (PubMed id 11392499)9 Morita T....Seishima M. (Ann. Clin. Biochem. 2001)
    632. IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment. (PubMed id 11798468)9 Guillemin G.J....Brew B.J. (amp 2001)

    (in PubMed, OMIM, and NCBI Bookshelf)
    About This Section

    TryGeneCards Plus
     ANDOR
    Aliases
    Disorders
    Free Text  

      Query String
    PubMed
    OMIM
    NCBI Bookshelf
      (Note: In FireFox, select the above section and copy using Ctrl-C)

    (According to Entrez Gene, HGNC, AceView, euGenes, Ensembl, miRBase, ECgene, Kegg, and/or H-InvDB)
    About This Section

    TryGeneCards Plus
    Entrez Gene: 3620 HGNC: 6059 AceView: INDO Ensembl:ENSG00000131203 euGenes: HUgn3620
    ECgene: IDO1 Kegg: 3620 H-InvDB: IDO1

    (According to HUGE)
    About This Section

    TryGeneCards Plus
      --

    (According to PharmGKB, ATLAS, HORDE, IMGT, LEIDEN, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL, and/or others, e.g. Wikipedia and GeneReviews, via UniProtKB/Swiss-Prot)
    About This Section

    TryGeneCards Plus
    NameDescription
    PharmGKB entry for IDO1 Pharmacogenomics, SNPs, Pathways
    ATLAS Chromosomes in Cancer entry for IDO1 Genetics and Cytogenetics in Oncology and Haematology

    (Patent information from GeneIP,
    Licensable technologies from WIS Yeda, Salk, Tufts,
    IP news from LifeMap Sciences, Inc.)
    About This Section

    TryGeneCards Plus
    Patent Information for IDO1 gene:
    Search GeneIP for patents involving IDO1

    GeneCards and IP:
    Japan Patent Office Licenses GeneCards     European Patent Office Licenses GeneCards     Improving the IP Search



    (Antibodies, recombinant proteins, and assays from EMD Millipore, R&D Systems, OriGene, QIAGEN, GenScript, Cell Signaling Technology, Novus Biologicals, Sino Biological, Enzo Life Sciences, Abcam, ProSpec, Cloud-Clone Corp., Thermo Fisher Scientific, LSBio, eBioscience, and/or others, Gene Editing from DNA2.0. Clones from OriGene, GenScript, Sino Biological, DNA2.0, SwitchGear Genomics, Vector BioLabs, Addgene, Cell lines from GenScript, and ESI BIO, Flow cytometery from eBioscience, PCR Arrays from QIAGEN, Drugs and/or compounds from EMD Millipore, Tocris Bioscience, Enzo Life Sciences, and/or ApexBio, In Situ Hybridization Assays from
    Advanced Cell Diagnostics, Animal models from inGenious Targeting Laboratory, genOway)
    About This Section

    TryGeneCards Plus

     EMD Millipore Mono- and Polyclonal Antibodies for the study of IDO1
     Browse Kits and Assays available from EMD Millipore
     Browse Small Molecules at EMD Millipore
     Browse Purified and Recombinant Proteins at EMD Millipore
     
     EMD Millipore genomic analysis products

      
     Antibodies for IDO1 (Indoleamine 2,3-dioxygenase/IDO)   Browse Cell Culture Products  
     Browse ELISAs   Browse Flow Cytometry Kits  
     Browse Primer Pairs   Browse Enzyme Activity Assays/Reagents  
     Browse ELISpot/FluoroSpot Kits/Development Modules   Browse TFB/Immunoprecipitation Assays  
     Browse Apoptosis Detection Kits/Reagents   Browse Ubiquitin Proteasome Pathway (UPP) Assay Kits/Reagents  
     Browse DNA Damage/Repair Kits/Reagents   Browse Luminex Assays  
     Browse Cell Selection/Detection Kits/Reagents   Browse Secondary Antibodies/Controls/Staining Reagents  
     Recombinant/Natural Proteins for IDO1 (Indoleamine 2,3-dioxygenase/IDO)   Browse Stem Cell Products  
     Browse cDNA Clones   Proteome Profiler Antibody Arrays for IDO1 (Indoleamine 2,3-dioxygenase/IDO)  
     OriGene Antibodies for IDO1   OriGene RNAi products in human, mouse, rat for IDO1  
     OriGene qPCR primer pairs and template standards for IDO1   OriGene Protein Over-expression Lysate for IDO1  
     OriGene MassSpec something-or-other for IDO1   OriGene clones in human, mouse for IDO1  
     OriGene qSTAR qPCR primer pairs in human, mouse for IDO1   OriGene Purified Protein for IDO1  
     OriGene ORF clones in mouse, rat for IDO1   OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling  
     OriGene Custom Antibody Services for IDO1   OriGene Custom Protein Services for IDO1  

     
     
     Block miRNA regulation of human, mouse, rat IDO1 using miScript Target Protectors SeqTarget long-range PCR primers for resequencing IDO1
     DNA Methylation CpG Assay Predesigned for Pyrosequencing in human, mouse, rat IDO1 Predesigned siRNA for gene silencing in human, mouse, rat IDO1
     QuantiFast Probe-based Assays in human, mouse, rat IDO1 QuantiTect SYBR Green Assays in human, mouse, rat IDO1
     PCR Arrays including human, mouse, rat IDO1 Search Chromatin IP Primers for IDO1
     Pre-validated RT2 qPCR Primer Assay in human, mouse, rat IDO1  GeneGlobe Interaction Network for IDO1
     Regulatory tfbs in IDO1 promoter
     GenScript Custom Purified and Recombinant Proteins Services for IDO1 GenScript cDNA clones with any tag delivered in your preferred vector for IDO1
     GenScript Custom Assay Services for IDO1 GenScript Custom overexpressing Cell Line Services for IDO1
     CloneReady with Over 120,000 Genes  Gene Synthesis: Any Gene in Any Vector
     Vector-based siRNA and miRNA, Ready for Transfection Gene Mutant Library, Variants up to 10^11
     Plasmid Preparation Custom Peptide Services
     Antibodies & Assays for IDO1  (INDO)

     Search Tocris compounds for IDO1 (I23O1)
     Proteins for IDO1
     Browse Sino Biological Cell Lysates
     cDNA Clones for IDO1
     4000+ Proteins
     Search Sino Biological for antibodies, proteins & pathways
     Protein Production Services
     Transfection Reagents
     Protein A/G/L resins
     Isotyping reagents
     Drugs/Proteins for IDO1
     Search www.enzolifesciences.com for proteins, assays, substrates, inhibitors & antibodies

     Novus Tissue Slides
     IDO1 antibodies
     IDO1 proteins
     IDO1 lysates
     Antibodies for IDO1
     See all of Abcam's Antibodies, Kits and Proteins for IDO1
     Custom Antibody / Protein Production Service
     Bulk Purchasing
     Advantages of Rabbit Monoclonal antibodies
     Abcam protocols and scientific support
     Browse ProSpec Recombinant Proteins
     Browse Proteins at Cloud-Clone Corp.
     Browse Antibodies at Cloud-Clone Corp.
     Browse ELISAs at Cloud-Clone Corp.
     Browse CLIAs at Cloud-Clone Corp.



     Browse ESI BIO Cell Lines and PureStem Progenitors for IDO1
     Gene Synthesis
     Protein Engineering
     Variant Library Synthesis
     Codon Optimization
     Protein Production and Purification
     Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for IDO1
     SwitchGear 3'UTR luciferase reporter plasmids for IDO1
     SwitchGear Promoter luciferase reporter plasmids for IDO1
     ThermoFisher Antibody for IDO1
     Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat IDO1
     inGenious Targeting Laboratory: Let us create your new Knockout/Knockin mouse model for IDO1
     inGenious Targeting Laboratory: Contact us about creating complex and humanized mouse models for IDO1
     LSBio Antibodies in human, mouse, rat for IDO1
    Customized transgenic rodents for:
     Humanization
     Biomarker expression
     Off-target effect monitoring
     Translational medicine
     Tissue-specific gene expresssion
     Time-controlled gene expresssion
     Browse compounds at ApexBio
     Search Addgene for plasmids for IDO1
      Search eBioscience for proteins for IDO1
      Search eBioscience for elisas for IDO1
      eBioscience FlowRNA Probe Sets
           
    GeneCards Homepage - Last full update: 7 May 2014 - Incrementals: 9 May 2014 , 2 Jun 2014 , 26 Jun 2014 , 30 Jun 2014 , 21 Aug 2014 , 8 Sep 2014

    View Random Gene

    Category
    (GIFtS: )
    GIFtS Group
    The GeneCards human gene database gene index: 1 3 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 


    Developed at the Crown Human Genome Center, Department of Molecular Genetics, the Weizmann Institute of Science

    Hot genes      Disease genes      IDO1 gene at Home site.
    Version: 3.12.212 17 Sep 2014
    hostname: 356977-web1.xennexinc.com index build: 128 solr: 1.4